638 DAIRY PRODUCTS, CALCIUM AND RISK OF HEPATOCELLULAR CARCINOMA IN THE EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION (EPIC) STUDY (Englisch)
- Neue Suche nach: Duarte-Salles, T.
- Neue Suche nach: Fedirko, V.
- Neue Suche nach: Trichopoulou, A.
- Neue Suche nach: Bamia, C.
- Neue Suche nach: Romieu, I.
- Neue Suche nach: Jenab, M.
- Neue Suche nach: Duarte-Salles, T.
- Neue Suche nach: Fedirko, V.
- Neue Suche nach: Trichopoulou, A.
- Neue Suche nach: Bamia, C.
- Neue Suche nach: Romieu, I.
- Neue Suche nach: Jenab, M.
In:
JOURNAL OF HEPATOLOGY
;
58
;
S260
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:638 DAIRY PRODUCTS, CALCIUM AND RISK OF HEPATOCELLULAR CARCINOMA IN THE EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION (EPIC) STUDY
-
Beteiligte:Duarte-Salles, T. ( Autor:in ) / Fedirko, V. ( Autor:in ) / Trichopoulou, A. ( Autor:in ) / Bamia, C. ( Autor:in ) / Romieu, I. ( Autor:in ) / Jenab, M. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 58 ; S260
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:S260
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 58
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
FocusFriedman, S. L. et al. | 2013
- 3
-
The international vision of the Journal of HepatologySamuel, D. et al. | 2013
- 4
-
May you live in interesting timesThursz, Mark et al. | 2013
- 5
-
Autoimmune hepatitis: A life-long diseaseWeiler-Normann, C. / Lohse, A. W. et al. | 2013
- 8
-
From lung to liver: How does airborne particulate matter trigger NASH and systemic insulin resistance?Conklin, Daniel J. et al. | 2013
- 11
-
Myocardial injury in patients with chronic hepatitis C infectionMaruyama, S. / Koda, M. / Oyake, N. / Sato, H. / Fujii, Y. / Horie, Y. / Murawaki, Y. et al. | 2013
- 16
-
HCV NS5A and IRF9 compete for CypA bindingBobardt, M. / Hopkins, S. / Baugh, J. / Chatterji, U. / Hernandez, F. / Hiscott, J. / Sluder, A. / Lin, K. / Gallay, P. A. et al. | 2013
- 24
-
Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopesZiegler, S. / Ruhl, M. / Tenckhoff, H. / Wiese, M. / Heinemann, F. M. / Horn, P. A. / Spengler, U. / Neumann-Haefelin, C. / Nattermann, J. / Timm, J. et al. | 2013
- 31
-
All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled studyKielland, Knut Boe / Skaug, Kjell / Amundsen, Ellen J. / Dalgard, Olav et al. | 2013
- 38
-
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosisBajaj, J. S. / Ahluwalia, V. / Wade, J. B. / Sanyal, A. J. / White, M. B. / Noble, N. A. / Monteith, P. / Fuchs, M. / Sterling, R. K. / Luketic, V. et al. | 2013
- 45
-
Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance studyGarcia-Pagán, Juan Carlos / Di Pascoli, Marco / Caca, Karel / Laleman, Wim / Bureau, Cristophe / Appenrodt, Beate / Luca, Angelo / Zipprich, Alexander / Abraldes, Juan G. / Nevens, Frederik et al. | 2013
- 51
-
LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunctionNazar, A. / Guevara, M. / Sitges, M. / Terra, C. / Sola, E. / Guigou, C. / Arroyo, V. / Gines, P. et al. | 2013
- 58
-
Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironmentMotomura, Takashi / Shirabe, Ken / Mano, Yohei / Muto, Jun / Toshima, Takeo / Umemoto, Yuichiro / Fukuhara, Takasuke / Uchiyama, Hideaki / Ikegami, Toru / Yoshizumi, Tomoharu et al. | 2013
- 65
-
TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapyCozzolino, Angela Maria / Alonzi, Tonino / Santangelo, Laura / Mancone, Carmine / Conti, Beatrice / Steindler, Corinna / Musone, Mariateresa / Cicchini, Carla / Tripodi, Marco / Marchetti, Alessandra et al. | 2013
- 65
-
TGFb overrides HNF4a tumor suppressing activity through GSK3b inactivation: implication for hepatocellular carcinoma gene therapyCozzolino, A. M. / Alonzi, T. / Santangelo, L. / Mancone, C. / Conti, B. / Steindler, C. / Musone, M. / Cicchini, C. / Tripodi, M. / Marchetti, A. et al. | 2013
- 73
-
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progressionMemon, K. / Kulik, L. / Lewandowski, R. J. / Mulcahy, M. F. / Benson, A. B. / Ganger, D. / Riaz, A. / Gupta, R. / Vouche, M. / Gates, V. L. et al. | 2013
- 81
-
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO studyZaanan, Aziz / Williet, Nicolas / Hebbar, Mohamed / Dabakuyo, Tienhan Sandrine / Fartoux, Laetitia / Mansourbakht, Touraj / Dubreuil, Olivier / Rosmorduc, Olivier / Cattan, Stéphane / Bonnetain, Franck et al. | 2013
- 89
-
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factorsKim, Young-sun / Lim, Hyo Keun / Rhim, Hyunchul / Lee, Min Woo / Choi, Dongil / Lee, Won Jae / Paik, Seung Woon / Koh, Kwang Cheol / Lee, Joon Hyeok / Choi, Moon Seok et al. | 2013
- 98
-
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statinsMarrone, G. / Russo, L. / Rosado, E. / Hide, D. / Garcia-Cardena, G. / Garcia-Pagan, J. C. / Bosch, J. / Gracia-Sancho, J. et al. | 2013
- 104
-
Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and menBorkham-Kamphorst, Erawan / Zimmermann, Henning W. / Gassler, Nikolaus / Bissels, Ute / Bosio, Andreas / Tacke, Frank / Weiskirchen, Ralf / Kanse, Sandip M. et al. | 2013
- 112
-
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cellsCarambia, Antonella / Frenzel, Christian / Bruns, Oliver T. / Schwinge, Dorothee / Reimer, Rudolph / Hohenberg, Heinrich / Huber, Samuel / Tiegs, Gisa / Schramm, Christoph / Lohse, Ansgar W. et al. | 2013
- 119
-
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver diseaseCastro, R. E. / Ferreira, D. M. / Afonso, M. B. / Borralho, P. M. / Machado, M. V. / Cortez-Pinto, H. / Rodrigues, C. M. et al. | 2013
- 126
-
Low-density lipoprotein cholesterol and risk of gallstone disease: A Mendelian randomization study and meta-analysesStender, Stefan / Frikke-Schmidt, Ruth / Benn, Marianne / Nordestgaard, Børge G. / Tybjærg-Hansen, Anne et al. | 2013
- 134
-
Beyond plasma bilirubin: The effects of phototherapy and albumin on brain bilirubin levels in Gunn ratsCuperus, Frans J.C. / Schreuder, Andrea B. / van Imhoff, Deirdre E. / Vitek, Libor / Vanikova, Jana / Konickova, Renata / Ahlfors, Charles E. / Hulzebos, Christian V. / Verkade, Henkjan J. et al. | 2013
- 141
-
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remissionvan Gerven, Nicole M.F. / Verwer, Bart J. / Witte, Birgit I. / van Hoek, Bart / Coenraad, Minneke J. / van Erpecum, Karel J. / Beuers, Ulrich / van Buuren, Henk R. / de Man, Rob A. / Drenth, Joost P.H. et al. | 2013
- 148
-
Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal modelZheng, Z. / Xu, X. / Zhang, X. / Wang, A. / Zhang, C. / Huttemann, M. / Grossman, L. I. / Chen, L. C. / Rajagopalan, S. / Sun, Q. et al. | 2013
- 155
-
Bile acid transporters and regulatory nuclear receptors in the liver and beyondHalilbasic, Emina / Claudel, Thierry / Trauner, Michael et al. | 2013
- 169
-
Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinomaJiang, T. / Zhu, A. X. / Sahani, D. V. et al. | 2013
- 178
-
Liver sinusoidal endothelial cells in disease - And for therapy?Stutchfield, B. M. / Forbes, S. J. et al. | 2013
- 181
-
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: Mystery solved?Strazzabosco, M. / Fabris, L. et al. | 2013
- 184
-
Vitamin D for your patients with chronic hepatitis C?Rahman, Adeeb H. / Branch, Andrea D. et al. | 2013
- 190
-
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinomaPollicino, Teresa / Vegetti, Alberto / Saitta, Carlo / Ferrara, Francesca / Corradini, Elena / Raffa, Giuseppina / Pietrangelo, Antonello / Raimondo, Giovanni et al. | 2013
- 194
-
Transarterial therapies for hepatocellular carcinoma (HCC): A long way towards standardizationTsochatzis, E. A. / Meyer, T. / O'Beirne, J. / Burroughs, A. K. et al. | 2013
- 195
-
Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): A long way towards standardization"Park, J. W. / Kim, H. B. / Lee, I. J. et al. | 2013
- 195
-
Fondaparinux (Arixtra*) hepatotoxicity in a 6 year-old childOrostegui, L. / Medejel, N. / Kone-Paut, I. / Dreyfus, M. / Benhamou, D. et al. | 2013
- 199
-
Erratum to "Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus" [J Hepatol 2012;57:246-251]Roelandt, P. / Obeid, S. / Paeshuyse, J. / Vanhove, J. / Van Lommel, A. / Nahmias, Y. / Nevens, F. / Neyts, J. / Verfaillie, C. M. et al. | 2013
- 201
-
Corrigendum to: “EASL clinical practice guidelines: Management of chronic hepatitis B virus infection” [J Hepatol 2012;57:167–185]| 2013
- 205
-
Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?Thimme, R. / Dandri, M. et al. | 2013
- 210
-
Early hepatocellular carcinoma - Is there such a thing as too early?McCaughan, G. W. et al. | 2013
- 212
-
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United StatesBaxa, D. M. / Thekdi, A. D. / Golembieski, A. / Krishnan, P. V. / Sharif, O. / Kizy, A. / Shetron-Rama, L. / Jovanovich, J. / Chappell, B. J. / Snow-Lampart, A. et al. | 2013
- 217
-
Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapyCheng, Y. / Guindon, S. / Rodrigo, A. / Lim, S. G. et al. | 2013
- 225
-
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis BMicco, L. / Peppa, D. / Loggi, E. / Schurich, A. / Jefferson, L. / Cursaro, C. / Panno, A. M. / Bernardi, M. / Brander, C. / Bihl, F. et al. | 2013
- 234
-
Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosisTrebicka, J. / Anadol, E. / Elfimova, N. / Strack, I. / Roggendorf, M. / Viazov, S. / Wedemeyer, I. / Drebber, U. / Rockstroh, J. / Sauerbruch, T. et al. | 2013
- 240
-
Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic ratsGuillaume, M. / Rodriguez-Vilarrupla, A. / Gracia-Sancho, J. / Rosado, E. / Mancini, A. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2013
- 247
-
Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine greenKawaguchi, Y. / Ishizawa, T. / Miyata, Y. / Yamashita, S. / Masuda, K. / Satou, S. / Tamura, S. / Kaneko, J. / Sakamoto, Y. / Aoki, T. et al. | 2013
- 254
-
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide YDietrich, P. / Moleda, L. / Kees, F. / Muller, M. / Straub, R. H. / Hellerbrand, C. / Wiest, R. et al. | 2013
- 262
-
Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcomeRodriguez-Peralvarez, M. / Germani, G. / Papastergiou, V. / Tsochatzis, E. / Thalassinos, E. / Luong, T. V. / Rolando, N. / Dhillon, A. P. / Patch, D. / O'Beirne, J. et al. | 2013
- 271
-
Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese populationLing, Q. / Xie, H. / Lu, D. / Wei, X. / Gao, F. / Zhou, L. / Xu, X. / Zheng, S. et al. | 2013
- 278
-
Protective mechanisms of end-ischemic cold machine perfusion in DCD liver graftsSchlegel, A. / Rougemont, O. d. / Graf, R. / Clavien, P. A. / Dutkowski, P. et al. | 2013
- 287
-
Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomesBurra, P. / Germani, G. / Adam, R. / Karam, V. / Marzano, A. / Lampertico, P. / Salizzoni, M. / Filipponi, F. / Klempnauer, J. L. / Castaing, D. et al. | 2013
- 297
-
ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosisAn, J. / Mehrhof, F. / Harms, C. / Lattig-Tunnemann, G. / Lee, S. L. / Endres, M. / Li, M. / Sellge, G. / Mandic, A. D. / Trautwein, C. et al. | 2013
- 306
-
Marginal survival benefit in the treatment of early hepatocellular carcinomaMidorikawa, Y. / Takayama, T. / Shimada, K. / Nakayama, H. / Higaki, T. / Moriguchi, M. / Nara, S. / Tsuji, S. / Tanaka, M. et al. | 2013
- 312
-
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosisGuyot, E. / Sutton, A. / Rufat, P. / Laguillier, C. / Mansouri, A. / Moreau, R. / Ganne-Carrie, N. / Beaugrand, M. / Charnaux, N. / Trinchet, J. C. et al. | 2013
- 319
-
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse modelHeindryckx, F. / Coulon, S. / Terrie, E. / Casteleyn, C. / Stassen, J. M. / Geerts, A. / Libbrecht, L. / Allemeersch, J. / Carmeliet, P. / Colle, I. et al. | 2013
- 329
-
Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitisAl Mamari, S. / Djordjevic, J. / Halliday, J. S. / Chapman, R. W. et al. | 2013
- 335
-
Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cellsNoetel, A. / Elfimova, N. / Altmuller, J. / Becker, C. / Becker, D. / Lahr, W. / Nurnberg, P. / Wasmuth, H. / Teufel, A. / Buttner, R. et al. | 2013
- 342
-
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in miceByun, J. S. / Suh, Y. G. / Yi, H. S. / Lee, Y. S. / Jeong, W. I. et al. | 2013
- 350
-
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type ICalderaro, J. / Labrune, P. / Morcrette, G. / Rebouissou, S. / Franco, D. / Prevot, S. / Quaglia, A. / Bedossa, P. / Libbrecht, L. / Terracciano, L. et al. | 2013
- 358
-
Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in miceHoo, R. L. / Lee, I. P. / Zhou, M. / Wong, J. Y. / Hui, X. / Xu, A. / Lam, K. S. et al. | 2013
- 365
-
Alterations in the redox state and liver damage: Hints from the EASL Basic School of HepatologyTell, G. / Vascotto, C. / Tiribelli, C. et al. | 2013
- 375
-
Host-targeting agents for prevention and treatment of chronic hepatitis C - Perspectives and challengesZeisel, M. B. / Lupberger, J. / Fofana, I. / Baumert, T. F. et al. | 2013
- 385
-
Targeting gut flora to prevent progression of hepatocellular carcinomaDarnaud, M. / Faivre, J. / Moniaux, N. et al. | 2013
- 388
-
Hereditary conjugated hyperbilirubinaemia: 37years laterDhumeaux, D. / Erlinger, S. et al. | 2013
- 391
-
Triple therapy with first generation HCV protease inhibitors: Lead-in or no lead-in phase?Pascale, A. / Serfaty, L. et al. | 2013
- 395
-
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver diseaseLeung, T. M. / Nieto, N. et al. | 2013
- 399
-
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosisValenti, L. / Dongiovanni, P. / Maggioni, M. / Motta, B. M. / Rametta, R. / Milano, M. / Fargion, S. / Reggiani, P. / Fracanzani, A. L. et al. | 2013
- 402
-
IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patientsGarrett, M. E. / Abdelmalek, M. F. / Ashley-Koch, A. / Hauser, M. A. / Moylan, C. A. / Pang, H. / Diehl, A. M. / Tillmann, H. L. et al. | 2013
- 403
-
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients"Petta, S. / Craxi, A. et al. | 2013
- 405
-
Erratum to: "Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations" [J Hepatol 2011;55:838-845]Chen, X. / Lingala, S. / Khoobyari, S. / Nolta, J. / Zern, M. A. / Wu, J. et al. | 2013
- 409
-
Silibinin: An old drug in the high tech era of liver transplantationFerenci, P. / Beinhardt, S. et al. | 2013
- 412
-
Hepatitis C infection and presence of advanced fibrosis: Wait or treat? Why wait? There is no time to lose, is there?Tillmann, H. L. et al. | 2013
- 415
-
Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation periodMarino, Z. / Crespo, G. / D'Amato, M. / Brambilla, N. / Giacovelli, G. / Rovati, L. / Costa, J. / Navasa, M. / Forns, X. et al. | 2013
- 421
-
Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant periodBarcena, R. / Moreno, A. / Rodriguez-Gandia, M. A. / Albillos, A. / Arocena, C. / Blesa, C. / Garcia-Hoz, F. / Graus, J. / Nuno, J. / Lopez-Hervas, P. et al. | 2013
- 427
-
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysisKumada, T. / Toyoda, H. / Tada, T. / Kiriyama, S. / Tanikawa, M. / Hisanaga, Y. / Kanamori, A. / Niinomi, T. / Yasuda, S. / Andou, Y. et al. | 2013
- 434
-
The natural history of compensated HCV-related cirrhosis: A prospective long-term studyGomez, E. V. / Rodriguez, Y. S. / Bertot, L. C. / Gonzalez, A. T. / Perez, Y. M. / Soler, E. A. / Garcia, A. Y. / Blanco, L. P. et al. | 2013
- 445
-
Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)Lenz, O. / Vijgen, L. / Berke, J. M. / Cummings, M. D. / Fevery, B. / Peeters, M. / Smedt, G. D. / Moreno, C. / Picchio, G. et al. | 2013
- 452
-
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized studyPoynard, T. / Bruix, J. / Schiff, E. R. / Diago, M. / Berg, T. / Moreno-Otero, R. / Lyra, A. C. / Carrilho, F. / Griffel, L. H. / Boparai, N. et al. | 2013
- 460
-
Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in ScotlandMcDonald, S. A. / Hutchinson, S. J. / Palmateer, N. E. / Allen, E. / Cameron, S. O. / Goldberg, D. J. / Taylor, A. et al. | 2013
- 467
-
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infectionKitson, M. T. / Dore, G. J. / George, J. / Button, P. / McCaughan, G. W. / Crawford, D. H. / Sievert, W. / Weltman, M. D. / Cheng, W. S. / Roberts, S. K. et al. | 2013
- 473
-
Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, FranceBottero, J. / Boyd, A. / Gozlan, J. / Lemoine, M. / Carrat, F. / Collignon, A. / Boo, N. / Dhotte, P. / Varsat, B. / Muller, G. et al. | 2013
- 479
-
Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosisBruno, S. / Vierling, J. M. / Esteban, R. / Nyberg, L. M. / Tanno, H. / Goodman, Z. / Poordad, F. / Bacon, B. / Gottesdiener, K. / Pedicone, L. D. et al. | 2013
- 488
-
Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failureFoster, G. R. / Zeuzem, S. / Andreone, P. / Pol, S. / Lawitz, E. J. / Diago, M. / Roberts, S. / Pockros, P. J. / Younossi, Z. / Lonjon-Domanec, I. et al. | 2013
- 495
-
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter studyOgawa, E. / Furusyo, N. / Kajiwara, E. / Takahashi, K. / Nomura, H. / Maruyama, T. / Tanabe, Y. / Satoh, T. / Nakamuta, M. / Kotoh, K. et al. | 2013
- 502
-
Multi-target lentivirus specific to hepatocellular carcinoma: In vitro and in vivo studiesZhang, Y. W. / Niu, J. / Lu, X. / Yang, Y. x. / Zhao, H. w. / He, X. / Yin, G. W. / Wu, J. D. / Yan, D. L. / Sun, J. f. et al. | 2013
- 509
-
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaDiouf, M. / Filleron, T. / Barbare, J. C. / Fin, L. / Picard, C. / Bouche, O. / Dahan, L. / Paoletti, X. / Bonnetain, F. et al. | 2013
- 522
-
miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expressionLi, J. / Ghazwani, M. / Zhang, Y. / Lu, J. / Fan, J. / Gandhi, C. R. / Li, S. et al. | 2013
- 529
-
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitisWeiler-Normann, C. / Schramm, C. / Quaas, A. / Wiegard, C. / Glaubke, C. / Pannicke, N. / Moller, S. / Lohse, A. W. et al. | 2013
- 535
-
MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesisLiang, J. / Liu, C. / Qiao, A. / Cui, Y. / Zhang, H. / Cui, A. / Zhang, S. / Yang, Y. / Xiao, X. / Chen, Y. et al. | 2013
- 543
-
Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breathVerdam, F. J. / Dallinga, J. W. / Driessen, A. / Jonge, C. d. / Moonen, E. J. / van Berkel, J. B. / Luijk, J. / Bouvy, N. D. / Buurman, W. A. / Rensen, S. S. et al. | 2013
- 549
-
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver diseaseAravinthan, A. / Scarpini, C. / Tachtatzis, P. / Verma, S. / Penrhyn-Lowe, S. / Harvey, R. / Davies, S. E. / Allison, M. / Coleman, N. / Alexander, G. et al. | 2013
- 557
-
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in ChinaLi, H. / Dong, K. / Fang, Q. / Hou, X. / Zhou, M. / Bao, Y. / Xiang, K. / Xu, A. / Jia, W. et al. | 2013
- 564
-
Innate immunity and HCVHeim, M. H. et al. | 2013
- 575
-
The dynamic biliary epithelia: Molecules, pathways, and diseaseO'Hara, S. P. / Tabibian, J. H. / Splinter, P. L. / LaRusso, N. F. et al. | 2013
- 583
-
Perspectives and challenges of interferon-free therapy for chronic hepatitis CLange, C. M. / Zeuzem, S. et al. | 2013
- 593
-
The burden of liver disease in Europe: A review of available epidemiological dataBlachier, M. / Leleu, H. / Peck-Radosavljevic, M. / Valla, D. C. / Roudot-Thoraval, F. et al. | 2013
- 609
-
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rateCescon, M. / Cucchetti, A. / Ravaioli, M. / Pinna, A. D. et al. | 2013
- 619
-
AMPK regulates macrophage polarization in adipose tissue inflammation and NASHWeng, S. Y. / Schuppan, D. et al. | 2013
- 622
-
Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt/b-cateninTeufel, A. / Marquardt, J. U. / Galle, P. R. et al. | 2013
- 625
-
Induced pluripotent stem cells: From Nobel Prizes to clinical applicationsRashid, S. T. / Alexander, G. J. et al. | 2013
- 630
-
A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production)Moreira Silva, H. / Reis, G. / Guedes, M. / Cleto, E. / Vizcaino, J. R. / Kelly, D. / Gennery, A. R. / Santos Silva, E. et al. | 2013
- 634
-
Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulationSamson, S. L. / Bajaj, M. et al. | 2013
- 635
-
Reply to: "Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation"Fishman, S. / Zvibel, I. et al. | 2013
- 636
-
Are Hedgehog and Wnt/b-catenin pathways involved in hepatitis C virus-mediated EMT?Conti, B. / Minutolo, A. / Arciello, M. / Balsano, C. et al. | 2013
- 637
-
Reply to: "Are Hedgehog and Wnt/b-catenin pathways involved in hepatitis C virus-mediated EMT?":Persistent activation of Hedgehog or Wnt/b-catenin pathways is not involved in EMT mediated by HCV NS5A proteinGregoire, D. / Akkari, L. / Carenco, C. / Hibner, U. et al. | 2013
- 638
-
Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains openThevenot, T. / Monnet, E. / Martino, V. D. et al. | 2013
- 640
-
Reply to: "Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open"Guevara, M. / Arroyo, V. / Gines, P. et al. | 2013
- 643
-
Interferon free regimens for the “difficult-to-treat”: Are we there?Londoño, M. C. / Lens, S. / Forns, X. et al. | 2013
- 646
-
Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevirKarino, Y. / Toyota, J. / Ikeda, K. / Suzuki, F. / Chayama, K. / Kawakami, Y. / Ishikawa, H. / Watanabe, H. / Hernandez, D. / Yu, F. et al. | 2013
- 655
-
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment optionsSuzuki, Y. / Ikeda, K. / Suzuki, F. / Toyota, J. / Karino, Y. / Chayama, K. / Kawakami, Y. / Ishikawa, H. / Watanabe, H. / Hu, W. et al. | 2013
- 663
-
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: A randomized, 28-day, dose-ranging trialRodriguez-Torres, M. / Lawitz, E. / Kowdley, K. V. / Nelson, D. R. / DeJesus, E. / McHutchison, J. G. / Cornpropst, M. T. / Mader, M. / Albanis, E. / Jiang, D. et al. | 2013
- 669
-
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionRau, M. / Stickel, F. / Russmann, S. / Manser, C. N. / Becker, P. P. / Weisskopf, M. / Schmitt, J. / Dill, M. T. / Dufour, J. F. / Moradpour, D. et al. | 2013
- 676
-
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikelyChevaliez, S. p. / Hézode, C. / Bahrami, S. p. / Grare, M. / Pawlotsky, J. M. et al. | 2013
- 684
-
Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in TaiwanSu, F. H. / Chu, F. Y. / Bai, C. H. / Lin, Y. S. / Hsueh, Y. M. / Sung, F. C. / Yeh, C. C. et al. | 2013
- 690
-
Hepatitis B screening: Who to target? A French sexually transmitted infection clinic experienceSpenatto, N. / Boulinguez, S. / Mularczyk, M. / Molinier, L. / Bureau, C. / Saune, K. / Viraben, R. et al. | 2013
- 698
-
Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatmentsTryc, A. B. / Goldbecker, A. / Berding, G. / Rümke, S. / Afshar, K. / Shahrezaei, G. H. / Pflugrad, H. / Barg-Hock, H. / Strassburg, C. P. / Hecker, H. et al. | 2013
- 706
-
Increased incidence of orthopedic fractures in cirrhotic patients: A nationwide population-based studyTsai, C. F. / Liu, C. J. / Chen, T. J. / Chu, C. J. / Lin, H. C. / Lee, F. Y. / Su, T. P. / Lu, C. L. et al. | 2013
- 715
-
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort studyAngelico, M. / Nardi, A. / Marianelli, T. / Caccamo, L. / Romagnoli, R. / Tisone, G. / Pinna, A. D. / Avolio, A. W. / Fagiuoli, S. / Burra, P. et al. | 2013
- 724
-
Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide surveyHasegawa, K. / Kokudo, N. / Makuuchi, M. / Izumi, N. / Ichida, T. / Kudo, M. / Ku, Y. / Sakamoto, M. / Nakashima, O. / Matsui, O. et al. | 2013
- 730
-
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosisLin, C. W. / Lin, C. C. / Mo, L. R. / Chang, C. Y. / Perng, D. S. / Hsu, C. C. / Lo, G. H. / Chen, Y. S. / Yen, Y. C. / Hu, J. T. et al. | 2013
- 736
-
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosisRoderburg, C. / Luedde, M. / Vargas Cardenas, D. / Vucur, M. / Mollnow, T. / Zimmermann, H. W. / Koch, A. / Hellerbrand, C. / Weiskirchen, R. / Frey, N. et al. | 2013
- 743
-
Sequential induction of type I and II interferons mediates a long-lasting gene induction in the liver in response to a novel toll-like receptor 9 agonistMakowska, Z. / Blumer, T. / Duong, F. o. / La Monica, N. / Kandimalla, E. R. / Heim, M. H. et al. | 2013
- 750
-
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: Possible implications for sclerosing cholangitisMarzioni, M. / Saccomanno, S. / Agostinelli, L. / Rychlicki, C. / Minicis, S. D. / Pierantonelli, I. / Trauner, M. / Fickert, P. / Müller, T. / Shanmukhappa, K. et al. | 2013
- 757
-
Cardiac structure and function are altered in adults with non-alcoholic fatty liver diseaseHallsworth, K. / Hollingsworth, K. G. / Thoma, C. / Jakovljevic, D. / MacGowan, G. A. / Anstee, Q. M. / Taylor, R. / Day, C. P. / Trenell, M. I. et al. | 2013
- 763
-
Mouse KLF11 regulates hepatic lipid metabolismZhang, H. / Chen, Q. / Yang, M. / Zhu, B. / Cui, Y. / Xue, Y. / Gong, N. / Cui, A. / Wang, M. / Shen, L. et al. | 2013
- 771
-
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver diseaseCentis, E. / Moscatiello, S. / Bugianesi, E. / Bellentani, S. / Fracanzani, A. L. / Calugi, S. / Petta, S. / Dalle Grave, R. / Marchesini, G. et al. | 2013
- 778
-
Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitisChatterjee, S. / Ganini, D. / Tokar, E. J. / Kumar, A. / Das, S. / Corbett, J. / Kadiiska, M. B. / Waalkes, M. P. / Diehl, A. M. / Mason, R. P. et al. | 2013
- 785
-
Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver diseaseDerdak, Z. / Villegas, K. A. / Harb, R. / Wu, A. M. / Sousa, A. / Wands, J. R. et al. | 2013
- 792
-
Clinical management of drug–drug interactions in HCV therapy: Challenges and solutionsBurger, D. / Back, D. / Buggisch, P. / Buti, M. / Craxí, A. / Foster, G. / Klinker, H. / Larrey, D. / Nikitin, I. / Pol, S. et al. | 2013
- 801
-
Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteinsWalenbergh, S. M. / Koek, G. H. / Bieghs, V. / Shiri-Sverdlov, R. et al. | 2013
- 811
-
Donor-recipient matching: Myths and realitiesBriceño, J. / Ciria, R. / de la Mata, M. et al. | 2013
- 821
-
miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivoZeisel, M. B. / Pfeffer, S. b. / Baumert, T. F. et al. | 2013
- 824
-
Drug-induced liver injury in obesityFromenty, B. et al. | 2013
- 827
-
Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiencyElias, J. E. / Mackie, I. / Eapen, C. E. / Chu, P. / Shaw, J. C. / Elias, E. et al. | 2013
- 831
-
Prediction of liver fibrosis progression by non-invasive tests in chronic hepatitis C: The impact of validationSebastiani, G. / Ghali, P. / Wong, P. / Deschenes, M. et al. | 2013
- 832
-
Reply to: “Prediction of liver fibrosis progression by non-invasive tests in chronic hepatitis C: The impact of validation”Rocco, A. / Compare, D. / Nardone, G. et al. | 2013
- 833
-
Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infectionSperl, J. / Frankova, S. / Spicak, J. / Viklicky, O. et al. | 2013
- 835
-
Reply to: “Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection”Cosconea, S. / Fontaine, H. l. / Pol, S. et al. | 2013
- 836
-
The role of CD147 in liver injury: “The truth is in the details”McLennan, S. V. / Warner, F. J. / Shackel, N. A. et al. | 2013
- 837
-
Reply to: “The role of CD147 in liver injury: The truth is in the details”Zhang, D. W. / Chen, Z. N. / Bian, H. et al. | 2013
- 838
-
Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: Is it really the effect of the therapy?Toyoda, H. / Kumada, T. / Tada, T. et al. | 2013
- 839
-
Reply to: “Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: Is it really the effect of the therapy?”Ogawa, E. / Furusyo, N. / Hayashi, J. et al. | 2013
- 840
-
Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modelingDahari, H. / Cotler, S. J. / Layden, T. J. / Perelson, A. S. et al. | 2013
- 842
-
Reply to: “Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling”Howell, C. D. / Jin, R. / Dowling, T. C. et al. | 2013
- 847
-
IL28B testing in a rapidly changing world: Still relevant?King, L. Y. / Chung, R. T. et al. | 2013
- 850
-
A new method for therapeutic paracentesis: The automated low flow pump system. Comments in the context of the history of paracentesisArroyo, V. et al. | 2013
- 853
-
A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infectionLiu, J. / Lee, M. H. / Batrla-Utermann, R. / Jen, C. L. / Iloeje, U. H. / Lu, S. N. / Wang, L. Y. / You, S. L. / Hsiao, C. K. / Yang, H. I. et al. | 2013
- 861
-
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virusVolz, T. / Allweiss, L. / MBarek, M. B. / Warlich, M. / Lohse, A. W. / Pollok, J. M. / Alexandrov, A. / Urban, S. / Petersen, J. / Lutgehetmann, M. et al. | 2013
- 868
-
g-H2AX+CD8+ T lymphocytes cannot respond to IFN-a, IL-2 or IL-6 in chronic hepatitis C virus infectionHoare, M. / Shankar, A. / Shah, M. / Rushbrook, S. / Gelson, W. / Davies, S. / Akbar, A. / Alexander, G. J. et al. | 2013
- 875
-
A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC regionUrabe, Y. / Ochi, H. / Kato, N. / Kumar, V. / Takahashi, A. / Muroyama, R. / Hosono, N. / Otsuka, M. / Tateishi, R. / Lo, P. H. et al. | 2013
- 883
-
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failurePol, S. / Aerssens, J. / Zeuzem, S. / Andreone, P. / Lawitz, E. J. / Roberts, S. / Younossi, Z. / Foster, G. R. / Focaccia, R. / Horban, A. et al. | 2013
- 890
-
Hepatitis Outreach Network: A practical strategy for hepatitis screening with linkage to care in foreign-born communitiesPerumalswami, P. V. / Factor, S. H. / Kapelusznik, L. / Friedman, S. L. / Pan, C. Q. / Chang, C. / Di Clemente, F. / Dieterich, D. T. et al. | 2013
- 898
-
Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis BSonneveld, M. J. / Arends, P. / Boonstra, A. / Hansen, B. E. / Janssen, H. L. et al. | 2013
- 904
-
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic ratsDi Pascoli, M. / Divi, M. / Rodriguez-Vilarrupla, A. / Rosado, E. / Gracia-Sancho, J. / Vilaseca, M. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2013
- 911
-
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosisReiberger, T. / Ferlitsch, A. / Payer, B. A. / Mandorfer, M. / Heinisch, B. B. / Hayden, H. / Lammert, F. / Trauner, M. / Peck-Radosavljevic, M. / Vogelsang, H. et al. | 2013
- 922
-
Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and efficacy studyBellot, P. / Welker, M. W. / Soriano, G. / von Schaewen, M. / Appenrodt, B. / Wiest, R. / Whittaker, S. / Tzonev, R. / Handshiev, S. / Verslype, C. et al. | 2013
- 928
-
Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standardPoynard, T. / Munteanu, M. / Luckina, E. / Perazzo, H. / Ngo, Y. / Royer, L. / Fedchuk, L. / Sattonnet, F. / Pais, R. / Lebray, P. et al. | 2013
- 936
-
Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosisGandoura, S. / Weiss, E. / Rautou, P. E. / Fasseu, M. / Gustot, T. / Lemoine, F. / Hurtado-Nedelec, M. / Hego, C. / Vadrot, N. / Elkrief, L. et al. | 2013
- 949
-
Modulation of the fecal bile acid profile by gut microbiota in cirrhosisKakiyama, G. / Pandak, W. M. / Gillevet, P. M. / Hylemon, P. B. / Heuman, D. M. / Daita, K. / Takei, H. / Muto, A. / Nittono, H. / Ridlon, J. M. et al. | 2013
- 956
-
Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosisWaidmann, O. / Brunner, F. / Herrmann, E. / Zeuzem, S. / Piiper, A. / Kronenberger, B. et al. | 2013
- 962
-
Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantationManousou, P. / Burroughs, A. K. / Sochatzis, E. T. / Isgro, G. / Hall, A. / Green, A. / Calvaruso, V. / Ma, G. L. / Gale, J. / Burgess, G. et al. | 2013
- 969
-
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantationBiggins, S. W. / Trotter, J. / Gralla, J. / Burton, J. R. / Bambha, K. M. / Dodge, J. / Brocato, M. / Cheng, L. / McQueen, M. / Forman, L. et al. | 2013
- 977
-
The functional impairment of HCC-infiltrating gd T cells, partially mediated by regulatory T cells in a TGFb- and IL-10-dependent mannerYi, Y. / He, H. W. / Wang, J. X. / Cai, X. Y. / Li, Y. W. / Zhou, J. / Cheng, Y. F. / Jin, J. J. / Fan, J. / Qiu, S. J. et al. | 2013
- 984
-
Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptorDucheix, S. / Montagner, A. / Polizzi, A. / Lasserre, F. / Marmugi, A. / Bertrand-Michel, J. / Podechard, N. / Al Saati, T. / Chetiveaux, M. / Baron, S. et al. | 2013
- 993
-
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in miceLin, C. W. / Zhang, H. / Li, M. / Xiong, X. / Chen, X. / Dong, X. C. / Yin, X. M. et al. | 2013
- 1000
-
Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosisBechmann, L. P. / Vetter, D. / Ishida, J. / Hannivoort, R. A. / Lang, U. E. / Kocabayoglu, P. / Fiel, M. I. / Munoz, U. / Patman, G. L. / Ge, F. et al. | 2013
- 1007
-
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisalMachado, M. V. / Cortez-Pinto, H. et al. | 2013
- 1020
-
The gut microbiota and the liver. Pathophysiological and clinical implicationsQuigley, E. M. / Stanton, C. / Murphy, E. F. et al. | 2013
- 1028
-
Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatmentBerenguer, M. / Schuppan, D. et al. | 2013
- 1042
-
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencingChaiteerakij, R. / Roberts, L. R. et al. | 2013
- 1045
-
Hepatitis E virus infection: Multiple faces of an underestimated problemPischke, S. / Wedemeyer, H. et al. | 2013
- 1047
-
Therapeutic strategies in inflammasome mediated diseases of the liverHoque, R. / Vodovotz, Y. / Mehal, W. et al. | 2013
- 1053
-
Clinical evidence for thrombospondin-1 as a relevant suppressor of liver regenerationStarlinger, P. / Schauer, D. / Alidzanovic, L. / Zikeli, S. / Gebhardt, K. / Luf, F. / Fleischmann, E. / Perisanidis, B. / Gruenberger, B. / Gruenberger, T. et al. | 2013
- 1055
-
Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheresGarin, E. / Rolland, Y. / Boucher, E. et al. | 2013
- 1056
-
Reply to: "Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres"Sangro, B. / Inarrairaegui, M. / Bilbao, J. I. et al. | 2013
- 1057
-
Identification of chronic hepatitis BLai, S. W. / Liao, K. F. et al. | 2013
- 1058
-
Reply to: "Identification of chronic hepatitis B"Veldhuijzen, I. K. / Janssen, H. L. et al. | 2013
- 1059
-
New onset diabetes after transplantation: A type 1.5 diabetes or latent autoimmune diabetes of adults?Eshraghian, A. et al. | 2013
- 1060
-
Reply to: "New onset diabetes after transplantation: A type 1.5 diabetes or latent autoimmune diabetes of adults?"Ling, Q. / Xu, X. / Dong, F. / Zheng, S. et al. | 2013
- 1062
-
Erratum to: "Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries" [J Hepatol 2011;55:183-191]Hadziyannis, S. J. et al. | 2013
- 1065
-
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?Karimian, N. / op den Dries, S. / Porte, R. J. et al. | 2013
- 1068
-
HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcriptionHuang, Y. / Tai, A. W. / Tong, S. / Lok, A. S. et al. | 2013
- 1074
-
Early infection events highlight the limited transmissibility of hepatitis C virus in vitroMeredith, L. W. / Harris, H. J. / Wilson, G. K. / Fletcher, N. F. / Balfe, P. / McKeating, J. A. et al. | 2013
- 1081
-
TIP47 plays a crucial role in the life cycle of hepatitis C virusPloen, D. / Hafirassou, M. L. / Himmelsbach, K. / Sauter, D. / Biniossek, M. L. / Weiss, T. S. / Baumert, T. F. / Schuster, C. / Hildt, E. et al. | 2013
- 1089
-
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patientsMartinot-Peignoux, M. / Carvalho-Filho, R. / Lapalus, M. / Netto-Cardoso, A. C. / Lada, O. / Batrla, R. / Krause, F. / Asselah, T. / Marcellin, P. et al. | 2013
- 1096
-
Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis CSanai, F. M. / Mousa, D. / Al-Mdani, A. / Al-Shoail, G. / Al-Ashgar, H. / Al Meshari, K. / Al-Qahtani, A. / Saadeh, M. / Bzeizi, K. I. / Aleid, H. et al. | 2013
- 1104
-
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virusBerenguer, J. / Alvarez-Pellicer, J. / Carrero, A. / Von Wichmann, M. A. / López-Aldeguer, J. / Mallolas, J. / Galindo, M. a. / Van Den Eynde, E. / Téllez, M. a. / Quereda, C. et al. | 2013
- 1113
-
Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosisUrrunaga, N. H. / Singal, A. G. / Cuthbert, J. A. / Rockey, D. C. et al. | 2013
- 1119
-
Regional metabolic liver function measured in patients with cirrhosis by 2-[18F]fluoro-2-deoxy-d-galactose PET/CTSørensen, M. / Mikkelsen, K. S. / Frisch, K. / Villadsen, G. E. / Keiding, S. et al. | 2013
- 1125
-
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier functionDu Plessis, J. / Vanheel, H. / Janssen, C. E. / Roos, L. / Slavik, T. / Stivaktas, P. I. / Nieuwoudt, M. / van Wyk, S. G. / Vieira, W. / Pretorius, E. et al. | 2013
- 1133
-
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantationBrunner, S. M. / Junger, H. / Ruemmele, P. / Schnitzbauer, A. A. / Doenecke, A. / Kirchner, G. I. / Farkas, S. A. / Loss, M. / Scherer, M. N. / Schlitt, H. J. et al. | 2013
- 1140
-
Simvastatin maintains function and viability of steatotic rat livers procured for transplantationGracia-Sancho, J. / GarcÃa-Calderó, H. c. / Hide, D. / Marrone, G. / Guixé-Muntet, S. / Peralta, C. / GarcÃa-Pagán, J. C. / Abraldes, J. G. / Bosch, J. et al. | 2013
- 1147
-
Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesisRibback, S. / Calvisi, D. F. / Cigliano, A. / Sailer, V. / Peters, M. / Rausch, J. / Heidecke, C. D. / Birth, M. / Dombrowski, F. et al. | 2013
- 1157
-
SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCCYang, S. T. / Yen, C. J. / Lai, C. H. / Lin, Y. J. / Chang, K. C. / Lee, J. C. / Liu, Y. W. / Chang-Liao, P. Y. / Hsu, L. S. / Chang, W. C. et al. | 2013
- 1165
-
Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinomaLaw, P. T. / Qin, H. / Ching, A. K. / Lai, K. P. / Co, N. N. / He, M. / Lung, R. W. / Chan, A. W. / Chan, T. F. / Wong, N. et al. | 2013
- 1174
-
Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomyToyoda, H. / Kumada, T. / Tada, T. / Niinomi, T. / Ito, T. / Sone, Y. / Kaneoka, Y. / Maeda, A. et al. | 2013
- 1181
-
Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationJung, E. S. / Kim, J. H. / Yoon, E. L. / Lee, H. J. / Lee, S. J. / Suh, S. J. / Lee, B. J. / Seo, Y. S. / Yim, H. J. / Seo, T. S. et al. | 2013
- 1188
-
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosisIavarone, M. / Piscaglia, F. / Vavassori, S. / Galassi, M. / Sangiovanni, A. / Venerandi, L. / Forzenigo, L. V. / Golfieri, R. / Bolondi, L. / Colombo, M. et al. | 2013
- 1194
-
Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failureBalasubramaniyan, V. / Dhar, D. K. / Warner, A. E. / Vivien Li, W. Y. / Amiri, A. F. / Bright, B. / Mookerjee, R. P. / Davies, N. A. / Becker, D. L. / Jalan, R. et al. | 2013
- 1201
-
Differential effects of norUDCA and UDCA in obstructive cholestasis in miceFickert, P. / Pollheimer, M. J. / Silbert, D. / Moustafa, T. / Halilbasic, E. / Krones, E. / Durchschein, F. / Thüringer, A. / Zollner, G. / Denk, H. et al. | 2013
- 1209
-
Improving outcomes of biliary atresia: French national series 1986–2009Chardot, C. / Buet, C. / Serinet, M. O. / Golmard, J. L. / Lachaux, A. / Roquelaure, B. / Gottrand, F. d. / Broué, P. / Dabadie, A. / Gauthier, F. d. et al. | 2013
- 1218
-
A 360-degree overview of paediatric NAFLD: Recent insightsNobili, V. / Svegliati-Baroni, G. / Alisi, A. / Miele, L. / Valenti, L. / Vajro, P. et al. | 2013
- 1230
-
Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed diseaseBernstein, D. L. / Hülkova, H. / Bialer, M. G. / Desnick, R. J. et al. | 2013
- 1244
-
Notch-driven carcinogenesis: The merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtypeRazumilava, N. / Gores, G. J. et al. | 2013
- 1246
-
A bile acid transporter as a candidate receptor for hepatitis B and D virus entryXiao, F. / McKeating, J. A. / Baumert, T. F. et al. | 2013
- 1249
-
Bariatric surgery for curing NASH in the morbidly obese?Lassailly, G. / Caïazzo, R. / Pattou, F. o. / Mathurin, P. et al. | 2013
- 1252
-
Precision-cut liver slices: A tool to model the liver ex vivoOlinga, P. / Schuppan, D. et al. | 2013
- 1254
-
Metronomic cyclophosphamide: An alternative treatment for hepatic epithelioid hemangioendotheliomaLakkis, Z. / Kim, S. / Delabrousse, E. / Jary, M. / Nguyen, T. / Mantion, G. / Heyd, B. / Lassabe, C. / Borg, C. et al. | 2013
- 1258
-
Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis deltaOuzan, D. / Pénaranda, G. / Joly, H. l. / Halfon, P. et al. | 2013
- 1259
-
Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosisBruno, S. / Mangia, A. et al. | 2013
- 1260
-
Response assessment methodologies in hepatocellular carcinoma: Complexities in the era of local and systemic treatmentsSalem, R. / Miller, F. H. / Yaghmai, V. / Lewandowski, R. J. et al. | 2013
- 1260
-
Reply to: “Usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosisâ€Foster, G. R. et al. | 2013
- 1262
-
Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosisJi, F. / Zhang, S. / Deng, H. / Li, Z. et al. | 2013
- 1264
-
Regular coffee: A magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLDTrovato, G. M. / Martines, G. F. / Trovato, F. M. / Catalano, D. et al. | 2013
- 1265
-
Reply to: “Regular coffee: A magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLDâ€Anty, R. / Marjoux, S. / Iannelli, A. / Pariente, A. / Tran, A. et al. | 2013
- I
-
Guide for Authors| 2013
- S1
-
2 A FRAME-SHIFT VARIANT IN THE NOVEL IFNL4 GENE IS ASSOCIATED WITH IMPAIRED HCV CLEARANCEOBrien, T. / Pfeiffer, R. M. / Kuniholm, M. H. / Muchmore, B. / Aka, P. / Tang, W. / Chen, S. / Wang, A. / Astemborski, J. / Bonkovsky, H. L. et al. | 2013
- S2
-
4 THE EXTRACELLULAR MATRIX PROTEIN LAMININ ALPHA 5 REGULATES THE BEHAVIOUR OF HEPATIC PROGENITOR CELLS IN REGENERATING MOUSE LIVERWilliams, M. J. / Boulter, L. G. / Lu, W. Y. / Bird, T. G. / Fujiwara, H. / Watt, F. M. / Ffrench-Constant, C. / Forbes, S. J. et al. | 2013
- S3
-
6 ALL ORAL THERAPY WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT EXPERIENCED GT2/3 HCV-INFECTED PATIENTS: RESULTS OF THE PHASE 3 FUSION TRIALNelson, D. R. / Feld, J. / Kowdley, K. V. / Al-Assi, M. T. / Lin, M. / Mo, H. / McNally, J. / Brainard, D. M. / Symonds, W. T. / McHutchison, J. G. et al. | 2013
- S4
-
9 ASSOCIATION OF A GENETIC VARIANT OF THE TOLL-LIKE RECEPTOR 9 (TLR9) WITH SPONTANEOUS VIRAL CLEARANCE AND WITH INTERFERON RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTIONFischer, J. / Bohm, S. / Deichsel, D. / Knop, V. / Klinker, H. / Moller, B. / Rasenack, J. / Hinrichsen, H. / Spengler, U. / Buggisch, P. et al. | 2013
- S6
-
14 ALL-ORAL SOFOSBUVIR-BASED 12-WEEK REGIMENS FOR THE TREATMENT OF CHRONIC HCV INFECTION: THE ELECTRON STUDYGane, E. J. / Stedman, C. A. / Hyland, R. H. / Pang, P. S. / Ding, X. / Symonds, W. T. / McHutchison, J. G. et al. | 2013
- S9
-
21 10-YEARS PROGNOSTIC VALUE OF FIBROTEST AND STEATOTEST FOR LIVER-RELATED AND CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE-2 DIABETES AND/OR HYPERLIPIDEMIAPerazzo, H. / Munteanu, M. / Ngo, Y. / Huet, F. / Couteau, M. / Lebray, P. / Jacqueminet, S. / Imbert-Bismut, F. / Ratziu, V. / Hartemann-Heurtier, A. et al. | 2013
- S10
-
23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUPVerna, E. C. / Burton, J. R. / OLeary, J. G. / Lai, J. C. / Saxena, V. / Dodge, J. L. / Everson, G. T. / Trotter, J. F. / Stravitz, R. T. / Brown, R. S. et al. | 2013
- S12
-
28 A PROTEOMIC APPROACH TO IDENTIFY DYSREGULATED LIPID TRANSPORTER PROTEINS WHICH COULD PREDICT THE SEVERITY AND OUTCOME OF PATIENTS WITH ACUTE ON CHRONIC LIVER FAILUREMaras, J. S. / Das, S. / Jaswal, S. S. / Kumar, C. / Gawda, H. H. / Sathe, G. / Srikanth, S. / Pati, N. T. / Pandey, A. / Sarin, S. K. et al. | 2013
- S14
-
33 TARGETING THE Hippo PATHWAY TO IMPROVE THE REGENERATIVE CAPACITY OF THE LIVERLoforese, G. / Lugli, N. / Breu, K. / Keogh, A. / Candinas, D. / Halazonetis, T. / Stroka, D. et al. | 2013
- S15
-
36 NCAM AND PSA-NCAM MODULATE HEPATIC PROGENITOR CELL BEHAVIOR DURING LIVER DEVELOPMENT AND REGENERATIONTsuchiya, A. / Lu, W. Y. / Weinhold, B. / Boulter, L. / Stutchfield, B. M. / Williams, M. J. / Guest, R. V. / Minnis-Lyons, S. E. / MacKinnon, A. C. / Schwarzer, D. et al. | 2013
- S17
-
40 SEROCLEARANCE OF HBVDNA PREDICTS SIGNIFICANTLY REDUCED RISK OF HEPATOCELLULAR CARCINOMA AMONG THOSE WITH HIGH VIRAL LOADS: A TIME-DEPENDENT ANALYSIS OF SERIALLY MEASURED BIOMARKERSLiu, J. / Yang, H. I. / Lee, M. H. / Jen, C. L. / Lu, S. N. / Wang, L. Y. / You, S. L. / Iloeje, U. H. / Hsiao, C. K. / Chen, C. J. et al. | 2013
- S18
-
42 PREDICTING POST PARTUM HEPATITIS B VIRUS FLARES USING INNATE IMMUNE BIOMARKERSVisvanathan, K. / Skinner, N. A. / Lewin, S. / Giles, M. / Sasadeusz, J. et al. | 2013
- S21
-
49 LIFETIME COSTS ATTRIBUTABLE TO CHRONIC HEPATITIS C FROM THE FRENCH HEALTHCARE PERSPECTIVE (ANRS Ndegree12188)Schwarzinger, M. / Deuffic-Burban, S. / Mallet, V. / Pol, S. / Pageaux, G. P. / Canva-Delcambre, V. / Deltenre, P. / Roudot-Thoraval, F. / Larrey, D. / Dhumeaux, D. et al. | 2013
- S22
-
51 HCV TREATMENT RATE IN SELECT EUROPEAN COUNTRIES IN 2004-2010Razavi, H. / Estes, C. / Pasini, K. / Gower, E. / Hindman, S. et al. | 2013
- S23
-
54 THE IMPACT OF INJECTING NETWORKS ON HEPATITIS C TRANSMISSION AND TREATMENT IN PEOPLE WHO INJECT DRUGSHellard, M. / Rolls, D. / Davis, R. S. / Robins, G. / Pattison, P. / Higgs, P. / Aitken, C. / McBryde, E. et al. | 2013
- S26
-
58 HRas SIGNAL TRANSDUCTION MEDIATES HEPATITIS C VIRUS CELL ENTRY BY TRIGGERING THE ASSEMBLY OF THE HOST TETRASPANIN RECEPTOR COMPLEXZona, L. / Lupberger, J. / Thumann, C. / Ahmed-Adrar, N. S. / Harris, H. J. / Duong, F. H. / Heim, M. H. / Bachellier, P. / Zeisel, M. B. / Samuel, D. et al. | 2013
- S30
-
67 TELAPREVIR WITH ADJUSTED DOSE OF RIBAVIRIN IN NAIVE CHC-G1: EFFICACY AND TREATMENT IN CHC IN HEMODIALYSIS POPULATION. TARGET C (RCT)Basu, P. P. / Siriki, R. / Shah, N. J. / Farhat, S. / Mittimani, K. / Atluri, S. / Rahaman, M. / Brown, R. S. et al. | 2013
- S32
-
72 MAPPING EXPRESSION QUANTITATIVE TRAITS LOCI (eQTL) FOR PNPLA3 GENE IDENTIFIES ADDITIONAL SNPS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) INDEPENDENT OF rs738409Wang, X. / Onjiko, R. M. / Anstee, Q. M. / Ratziu, V. / Liu, Y. L. / Cordell, H. J. / Darlay, R. / Day, C. P. / Daly, A. K. / Chalasani, N. et al. | 2013
- S34
-
77 EMBOLIZATION OF LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS FOR REFRACTORY HEPATIC ENCEPHALOPATHY: A EUROPEAN MULTI-CENTER SURVEY ON SAFETY & EFFICACYLaleman, W. / Simon-Talero, M. / Maleux, G. / Perez, M. / Ameloot, K. / Soriano, G. / Villalba, J. / Garcia-Pagan, J. C. / Barrufet, M. / Jalan, R. et al. | 2013
- S35
-
80 SAFETY AND TOLERABILITY OF HUMAN MESENCHYMAL STEM CELLS FOR PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A PRELIMINARY STUDYFu, Q. / Jiang, S. / Wang, X. / Luo, Z. / Ni, L. / Ye, S. / Zhou, F. / Shi, L. / Chen, J. / Lv, G. et al. | 2013
- S36
-
82 THE TNF-alpha -238 G-ALLELE PREDISPOSES TO SEVERE BACTERIAL INFECTION IN PATIENTS WITH END-STAGE LIVER DISEASE ENLISTED FOR LIVER TRANSPLANTATIONBartakova, R. / de Mare-Bredemeijer, E. / Frankova, S. / Roelen, D. / Visseren, T. / Trunecka, P. / Spicak, J. / Metselaar, H. / Jirsa, M. / Kwekkeboom, J. et al. | 2013
- S38
-
87 A LIVER-SPECIFIC DELETION OF NIPP1 CAUSES BILE DUCT HYPERPLASIA AND AN INCREASED SENSITIVITY TO DIETHYLNITROSAMINE-INDUCED CARCINOMABoens, S. / Szeker, K. / Baes, M. / Roskams, T. / Beullens, M. / Van Eynde, A. / Bollen, M. et al. | 2013
- S39
-
90 HOXA13 AND HOTTIP EXPRESSION LEVELS PREDICT PATIENTS SURVIVAL AND METASTASIS FORMATION IN HEPATOCELLULAR CARCINOMAQuagliata, L. / Matter, M. / Piscuoglio, S. / Makowska, Z. / Heim, M. / Tornillo, L. / Cillo, C. / Terracciano, L. et al. | 2013
- S40
-
92 FORCED IL-6 SIGNALING IS SUFFICIENT TO PROMOTE MALIGNANT TRANSFORMATION IN TELOMERASE-IMMORTALIZED HUMAN FETAL HEPATOCYTES FOLLOWING CHALLENGE WITH OXIDATIVE STRESSHeim, D. / Parplys, A. C. / Rose-John, S. / Lohse, A. W. / Dikomey, E. / Wege, H. et al. | 2013
- S41
-
95 JNK1-DEPENDENT MODULATION OF miR-34a CONTRIBUTES TO APOPTOSIS INDUCED BY DEOXYCHOLIC ACID IN PRIMARY RAT HEPATOCYTESFerreira, D. M. / Afonso, M. B. / Rodrigues, P. M. / Borralho, P. M. / Rodrigues, C. M. / Castro, R. E. et al. | 2013
- S42
-
97 BILIARY STRICTURES AND RECURRENT DISEASE AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS - A LARGE, MULTICENTER COHORT ANALYSIS WITH LONG-TERM FOLLOW-UPHorn, T. / Pannicke, N. / Dechene, A. / Gotthardt, D. / Kirchner, G. / Reiter, F. P. / Herzer, K. / Lenzen, H. / Barg-Hock, H. / Sterneck, M. et al. | 2013
- S43
-
99 BASELINE PREDICTIVE FACTORS OF URSODEOXYCHOLIC ACID RESPONSE IN PRIMARY BILIARY CIRRHOSISCarbone, M. / Mells, G. / Cordell, H. J. / Heneghan, M. A. / Neuberger, J. M. / Donaldson, P. T. / Bathgate, A. J. / Burroughs, A. K. / Davies, M. H. / Day, D. B. et al. | 2013
- S45
-
103 EFFECT OF REGULAR TRAINING ON HEPATOCELLULAR CARCINOMA DEVELOPMENT IN HEPATOCYTE-SPECIFIC PTEN-DEFICIENT MICEPiguet, A. C. / Kellmann, P. / Reeves, H. L. / Terracciano, L. / Dufour, J. F. et al. | 2013
- S46
-
105 PHOSPHORUS MAGNETIC RESONANCE SPECTROSCOPY IN NON-ALCOHOLIC FATTY LIVER DISEASEAbrigo, J. / Wong, V. W. / Yeung, D. K. / Wong, G. L. / Chan, A. W. / Chan, H. L. / Chu, W. C. et al. | 2013
- S48
-
109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B)Piscaglia, F. / Pecorelli, A. / Venerandi, L. / Farinati, F. / Del Poggio, P. / Rapaccini, G. / Di Nolfo, M. A. / Benvegnu, L. / Zoli, M. / Borzio, F. et al. | 2013
- S51
-
115 INFLUENCE OF BMI AND ALCOHOL ON LIVER-RELATED MORBIDITY AND MORTALITY IN A COHORT OF 108,000 WOMEN FROM THE GENERAL POPULATION FROM UKCTOCSTrembling, P. M. / Apostolidou, S. / Parkes, J. / Ryan, A. / Gentry-Maharaj, A. / Tanwar, S. / Menon, U. / Rosenberg, W. M. et al. | 2013
- S52
-
117 SPONTANEOUS DECREASE IN LIVER INJURY DOES NOT STRONGLY PREDICT EVOLUTION OF PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH CORTICOSTEROIDSLouvet, A. / Artru, F. / Colin, M. / Lassailly, G. / Deltenre, P. / Canva-Delcambre, V. / Dharancy, S. / Mathurin, P. et al. | 2013
- S54
-
122 NON-SELECTIVE BETA-BLOCKERS MIGHT DECREASE SURVIVAL IN SEVERE ALCOHOLIC CIRRHOSISCales, P. / Bertrais, S. / Boursier, J. / Fouchard-Hubert, I. / Oberti, F. et al. | 2013
- S55
-
124 HEPATITIS DELTA INFECTION IN HUMANIZED UPA/SCID-MICE LEADS TO PRONOUNCED INDUCTION OF HUMAN-SPECIFIC INNATE IMMUNE RESPONSES AND CYTOKINE EXPRESSION IN COMPARISON TO HBV MONO-INFECTIONGiersch, K. / Lutgehetmann, M. / Volz, T. / Allweiss, L. / Braunschmidt, J. L. / Lohse, A. W. / Petersen, J. / Dandri, M. et al. | 2013
- S56
-
127 PROLIFERATION OF HEPATITIS B VIRUS INFECTED HUMAN HEPATOCYTES INDUCES SUPPRESSION OF VIRAL REPLICATION AND RAPID cccDNA DECREASE IN HUMANIZED MICEAllweiss, L. / Volz, T. / Giersch, K. / Lohse, A. W. / Petersen, J. / Lutgehetmann, M. / Dandri, M. et al. | 2013
- S57
-
130 A MULTIVALENT ADENOVIRUS-BASED IMMUNOTHERAPEUTIC FOR TREATMENT OF CHRONIC HEPATITIS B INDUCES BROAD, ROBUST AND POLYFUNCTIONAL T CELLS IN NAIVE AND HBV TOLERANT MICEMartin, P. / Dubois, C. / Jacquier, E. / Evlachev, A. / Boukhebza, H. / Dion, S. / Mancini-Bourgine, M. / Godon, O. / Findeli, A. / Schlesinger, Y. et al. | 2013
- S59
-
135 Jnk1 IN HEPATIC STELLATE CELLS MODULATES LIVER FIBROGENESIS IN VIVO AND IN VITROCubero, F. J. / Zhao, G. / Hatting, M. / Nevzorova, Y. A. / Schaefer, F. / Roskams, T. / Boekschoten, M. V. / Muller, M. / Davis, R. J. / Trautwein, C. et al. | 2013
- S60
-
138 CROSSTALK BETWEEN c-myc OVEREXPRESSING HEPATOCYTES AND HEPATIC STELLATE CELLS FACILITATES THE ONSET OF LIVER FIBROSISNevzorova, Y. A. / Hu, W. / Haas, U. / Freimuth, J. / Tacke, F. / Trautwein, C. / Liedtke, C. et al. | 2013
- S64
-
143 INTERNATIONAL BENCHMARKING IN LIVER TRANSPLANTATION IN EUROPECarbone, M. / Gimson, A. / Nardi, A. / Marianelli, T. / Barber, K. / Hudson, A. / Collett, D. / Neuberger, J. M. / Angelico, M. et al. | 2013
- S67
-
150 DONORS WITH KNOWN CANCER: AN UNDER-USED SOURCE OF ADDITIONAL LIVERSDesai, R. / Collett, D. / Evans, T. / Neuberger, J. et al. | 2013
- S69
-
155 EFFICACY AND SAFETY OF STANDARD ANTIVIRAL THERAPY IN CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION (LT)Londono, M. C. / Crespo, G. / Carrion, J. A. / Garcia-Retortillo, M. / Marino, Z. / Lens, S. / Fondevila, C. / Garcia-Valdecasas, J. C. / Navasa, M. / Forns, X. et al. | 2013
- S71
-
160 DONOR SPECIFIC ANTI-MHC CLASS II ANTIBODIES NEGATIVELY IMPACT ALLOGRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATIONIacob, S. / Beckebaum, S. / Lindemann, M. / Heinemann, F. M. / Rebmann, V. / Wu, G. / Schmidt, H. J. / Kabar, I. / Radtke, A. / Baba, H. A. et al. | 2013
- S73
-
165 THE EFFECT OF OBESITY, RENAL DYSFUNCTION AND ADVANCED AGE ON LONG-TERM SURVIVAL IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATIONDe Sciscio, P. / De Sciscio, M. / Lau, S. Y. / Wigg, A. et al. | 2013
- S75
-
170 IMPACT OF ADJUVANT CHEMOTHERAPY FOR HEPATOCELLULAR CARCINOMA BEYOND MILAN ON HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATIONMazzola, A. / Coilly, A. / Delvart, V. / Sebagh, M. / Roche, B. / Roque-Afonso, A. M. / Antonini, T. M. / Paule, B. / Duclos- Vallee, J. C. / Samuel, D. et al. | 2013
- S76
-
173 ATTITUDES OF PATIENTS, CARERS, CLINICIANS AND THE PUBLIC TO ACCESS TO LIVER TRANSPLANTATION IN THE UKParker, R. / Catling, J. / Neuberger, J. M. et al. | 2013
- S78
-
178 IMMUNOSUPPRESSION AND HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATIONRodriguez-Peralvarez, M. / Pieri, G. / Naveas, M. C. / Tsochatzis, E. / Garcia-Caparros, C. / OBeirne, J. / Poyato-Gonzalez, A. / Ferrin-Sanchez, G. / Patch, D. / Montero-Alvarez, J. L. et al. | 2013
- S79
-
180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIALSaliba, F. / Metselaar, H. J. / Beckebaum, S. / Duvoux, C. / Navasa, M. / Dong, G. / Lopez, P. / Nevens, F. et al. | 2013
- S82
-
187 PREDICTIVE MODELS AND RISK FACTORS OF KIDNEY FAILURE AFTER LIVER TRANSPLANTATIONWeismuller, T. J. / Lerch, C. / Evangelidou, E. / Manns, M. P. / Haller, H. G. / Strassburg, C. P. / Schiffer, M. et al. | 2013
- S83
-
189 THE PRESENCE OF HEMOLYTIC SPUR CELL-ANEMIA STRONGLY AFFECTS SURVIVAL IN PATIENTS WITH LIVER CIRRHOSISVasilieva, L. / Alexopoulou, A. / Kanellopoulou, T. / Pouriki, S. / Soultati, A. / Dourakis, S. P. et al. | 2013
- S84
-
192 RIFAXIMIN IMPROVES COGNITION AND ENDOTOXEMIA IN MINIMAL HEPATIC ENCEPHALOPATHY BY SHIFTING GUT MICROBIAL FUNCTIONALITY WITHOUT ALTERING THEIR ABUNDANCEBajaj, J. S. / Heuman, D. / Sanyal, A. / Hylemon, P. / Sterling, R. K. / Stravitz, R. T. / Fuchs, M. / Ridlon, J. M. / Daita, K. / Monteith, P. et al. | 2013
- S85
-
194 THROMBELASTOGRAPHY BEFORE INVASIVE PROCEDURES REDUCES HEMODERIVATES REQUIREMENT IN CIRRHOTIC PATIENTS WITH COAGULATION DISORDERS. A RANDOMIZED CONTROLLED TRIALDe Pietri, L. / Bianchini, M. / Montalti, R. / Di Maira, T. / De Maria, N. / Begliomini, B. / Gerunda, G. E. / Villa, E. et al. | 2013
- S86
-
197 FACTORS RELATED TO HOSPITALIZATION BUT NOT THE SEVERITY OF THE LIVER DISEASE INCREASE THE RISK OF NOSOCOMIAL INFECTION IN CIRRHOTIC PATIENTSDi Gregorio, V. / Giannelli, V. / Lucidi, C. / Giusto, M. / Imperatrice, B. / Iacovone, G. / Lattanzi, B. / Riggio, O. / Merli, M. et al. | 2013
- S87
-
200 EFFECT OF DIFFERENT SEDATION ON CRITICAL FLICKER FREQUENCY, A DIAGNOSTIC TOOL FOR MINIMAL ENCEPHALOPATHYGrunhage, F. / Seegmuller, A. / Lammert, F. et al. | 2013
- S89
-
205 LONG TERM OUTCOMES OF PORTOPULMONARY HYPERTENSION (POPH) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT)Khaderi, S. A. / Khan, R. / Blow, B. J. / Safdar, Z. / Vierling, J. M. / Stribling, R. J. / Goss, J. A. / Sussman, N. L. et al. | 2013
- S90
-
208 FREE 25(OH) VITAMIN D IS HIGHER IN CIRRHOTICS WITH SYNTHETIC DYSFUNCTION COMPARED WITH INDIVIDUALS WITHOUT LIVER DISEASE DESPITE TOTAL 25(OH)D DEFICIENCYLai, J. C. / Lizaola, B. / Kane, L. / Weyland, P. / Terrault, N. A. / Bikle, D. / Schwartz, J. B. et al. | 2013
- S92
-
213 BETABLOCKERS AND A PROPER USE OF PROTON PUMP INHIBITORS MAY REDUCE THE RISK OF BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTSImperatrice, B. / Lucidi, C. / Giannelli, V. / Di Gregorio, V. / Giusto, M. / Iacovone, G. / Lattanzi, B. / Riggio, O. / Merli, M. et al. | 2013
- S93
-
216 A GENETIC VARIANT IN THE PROMOTER OF PHOSPHATE ACTIVATED GLUTAMINASE (GLS) GENE PREDICTS THE RISK OF DEVELOPING HEPATIC ENCEPHALOPATHYMayer, L. B. / Gruenhage, F. / Lammert, F. et al. | 2013
- S95
-
222 DIAGNOSTIC VALUE OF PRESEPSIN IN CIRRHOTIC PATIENTSNovelli, G. / Morabito, V. / Ferretti, G. / Gugliemo, N. / Levi Sandri, G. B. / Rossi, M. / Berloco, P. B. et al. | 2013
- S96
-
225 THE PROTEIN FINGERPRINT TECHNOLOGY REFLECTS LIVER FUNCTION AND DETECTS CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISNielsen, M. J. / Leeming, D. J. / Karsdal, M. A. / Trebicka, J. / Byrjalsen, I. / Bendtsen, F. / Moller, S. / Krag, A. et al. | 2013
- S97
-
227 EVALUATION OF ADRENAL INSUFFICIENCY IN CIRRHOTIC PATIENTS IN KOREAShin, S. R. / Yoo, H. / Moh, I. H. / Park, S. H. / Lee, M. S. et al. | 2013
- S99
-
231 NOVEL NONINVASIVE MEASUREMENT OF HEPATIC VENOUS PRESSURE GRADIENT AND PORTAL PRESSURE FROM ANATOMIC CT ANGIOGRAPHYQi, X. / Zhou, F. / Lv, H. / Chen, H. / Xu, W. / Xing, S. / Yang, D. / Li, G. / Yang, C. et al. | 2013
- S101
-
236 SEXUAL DYSFUNCTION IN CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATIONRodriguez-Medina, B. / Ramos-Prol, A. / Ble, M. / Vinaixa, C. / Aguilera, V. / Rubin, A. / Garcia, M. / Prieto, M. / Berenguer, M. et al. | 2013
- S104
-
244 INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSISHorvath, A. / Leber, B. / Lemesch, S. / Stiegler, P. / Stauber, R. / Fickert, P. / Zollner, G. / Spindelboeck, W. / Krones, E. / Durchschein, F. et al. | 2013
- S106
-
249 HCC DIAGNOSED ON SURVEILLANCE PROGRAMMES: IMPACT ON STAGE AND OUTCOMEAhmed, A. / Mustafa, Z. / Rutherford, M. / Neilson, M. / Ballantyne, S. / Kasthuri, R. / Evans, J. / Forrest, E. H. / Gillespie, R. / Barclay, S. et al. | 2013
- S108
-
254 SINGLE HEPATOCELLULAR CARCINOMA SMALLER THAN 2 cm: ARE PERCUTANEOUS ETHANOL INJECTION AND RADIOFREQUENCY ABLATION EQUALLY EFFECTIVE?de Matthaeis, N. / Saviano, A. / De Sio, I. / Francica, G. / Brunello, F. / Cantamessa, A. / Giorgio, A. / Scognamiglio, U. / Fornari, F. / Giangregorio, F. et al. | 2013
- S109
-
257 SORAFENIB VERSUS RADIOEMBOLIZATION WITH Y90: CLINICAL EVALUATION AND SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND CIRRHOSISGaia, S. / Tabone, M. / Cantamessa, A. / Campion, D. / Carucci, P. / Grosso, M. / Risso, A. / Brunocilla, P. R. / Calvo, A. / Brunello, F. et al. | 2013
- S111
-
262 SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IS AFFECTED BY COMPLETE RESPONSE TO RADIO-FREQUENCY THERMAL ABLATION (RFTA)Cabibbo, G. / Maida, M. / Genco, C. / Di Marco, V. / Alessi, N. / Peralta, M. / Genova, C. / Craxi, A. / Camma, C. et al. | 2013
- S112
-
265 COST-EFFECTIVENESS OF HEPATIC RESECTION VERSUS PERCUTANEOUS ABLATION FOR HEPATOCELLULAR CARCINOMA WITHIN THE MILAN CRITERIACucchetti, A. / Piscaglia, F. / Cescon, M. / Colecchia, A. / Bolondi, L. / Pinna, A. D. et al. | 2013
- S114
-
269 INTRAHEPATIC CHOLANGIOCARCINOMA (I-CC) OR MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA (HCC-CC) IN PATIENTS UNDERGOING LIVER TRANSPLANTATION. A SPANISH CASE CONTROL MULTICENTER STUDYRodriguez-Lope, C. / Sapisochin, G. / Gastaca, M. / Ortiz de Urbina, J. / Lopez-Andujar, R. / Palacios, F. / Ramos, E. / Fabregat, J. / Castroagudin, J. F. / Varo, E. et al. | 2013
- S115
-
272 MORPHOPHENOTYPIC TACE PREDICTORS IN HEPATOCELLULAR CARCINOMASciarra, A. / Di Tommaso, L. / Ronot, M. / Spagnuolo, G. / Bedossa, P. / Roncalli, M. / Paradis, V. et al. | 2013
- S116
-
274 TIME TO PROGRESSION TO AFP AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIBVarela, M. / Castano-Fernandez, O. / Blanco Garcia, L. / Mesa-Alvarez, A. / de Llano, R. M. / Sanmartino, S. / Arguelles, B. / Martinez-Camblor, P. / Luyando, L. H. / Rodriguez, M. et al. | 2013
- S117
-
277 SORAFENIB ENHANCES EFFECTS OF TRANSARTERIAL CHEMOEMBOLISATION FOR HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSISFu, Q. / Zhang, Q. / Bai, X. / Hu, Q. / Liang, T. et al. | 2013
- S119
-
282 CELL CYCLE DEREGULATION BY HCV PROTEIN EXPRESSION, A POTENTIAL HEPATOCARCINOGENIC TRIGGERFlorimond, A. / Chouteau, P. / Defer, N. / Gaudin, A. / Lerat, H. / Pawlotsky, J. M. et al. | 2013
- S120
-
285 PLASMA MEMBRANE PROTEOMICS IDENTIFIES Notch1 AS A POTENTIAL REGULATOR OF Ras-INDUCED SENESCENCEHoare, M. / Weekes, M. P. / Matheson, N. J. / Menon, S. / Antrobus, R. / Lehner, P. J. / Narita, M. et al. | 2013
- S121
-
287 ICAM-1 AND VCAM-1 EXPRESSION IN HEPATOCYTE IS REGULATED BY NOD1 PATHWAYLassailly, G. / Cannesson, A. / Louvet, A. / Artru, F. / Gantier, E. / Maggiotto, F. / Dharancy, S. / Mathurin, P. / Dubuquoy, L. et al. | 2013
- S122
-
290 THE INTERACTION BETWEEN NF-kB ACTIVATION AND PPARg ACTIVATION IS REGULATED BY Cks1-Skp2-p27(kip1) PATHWAY AND MEDIATES TUMOR PROGRESSION IN HUMAN HEPATOCELLULAR CARCINOMAMaeda, S. / Kuboki, S. / Shimizu, H. / Shinoda, K. / Yoshidome, H. / Ohtsuka, M. / Kato, A. / Yoshitomi, H. / Furukawa, K. / Takayashiki, T. et al. | 2013
- S123
-
293 SORAFENIB PROVOKES IMPAIRED LIVER REGENERATION AND NON-APOPTOTIC HEPATOCYTE DAMAGE IN MICE BUT SELECTIVE APOPTOSIS IN ISOGENIC MALIGNANT HEPATOMA CELLSSonntag, R. / Gassler, N. / Trautwein, C. / Liedtke, C. et al. | 2013
- S125
-
298 ISOLATION AND CULTIVATION OF PURE HUMAN ADULT LIVER STEM CELL POPULATIONS FROM PATIENT LIVER RESECTATESFekete-Drimusz, N. / Meder, I. / Rudrich, U. / Preis, K. / Gutierrez, R. / Manns, M. P. / Vondran, F. / Bock, M. et al. | 2013
- S127
-
303 CHARACTERIZATION OF THE Met-TRIGGERED MIGRATORY AND INVASIVE RESPONSE IN LIVER PROGENITOR OVAL CELLSSanchez, A. / Suarez-Causado, A. / Caballero, D. / Roncero, C. / Garcia-Alvaro, M. / Fernandez, M. / Herrera, B. / Porras, A. / Fabregat, I. et al. | 2013
- S128
-
306 Pin1 IS DECREASED IN ISCHEMICALLY DAMAGED LIVER AND SUPPRESSED LIVER REGENERATION AFTER HEPATECTOMY THROUGH THE INHIBITION OF Pin1-MEDIATED NF-kB ACTIVATION IN HEPATOCYTESKuboki, S. / Shinoda, K. / Shimizu, H. / Maeda, S. / Yoshidome, H. / Ohtsuka, M. / Kato, A. / Yoshitomi, H. / Furukawa, K. / Takayashiki, T. et al. | 2013
- S129
-
309 TEMPORAL REGULATION OF Notch AND Wnt SIGNALLING IN HEPATIC PROGENITOR CELL-MEDIATED HEPATOCELLULAR REGENERATIONMinnis-Lyons, S. E. / Boulter, L. / Williams, M. J. / Guest, R. V. / Lu, W. Y. / Sansom, O. / Forbes, S. J. et al. | 2013
- S130
-
311 EX VIVO-EXPANDED PERIPHERAL CD34+ CELLS FOR CHRONICALLY INJURED LIVER TREATMENT: IN VITRO AND IN VIVO STUDIESNakamura, T. / Torimura, T. / Masuda, H. / Iwamoto, H. / Hashimoto, O. / Koga, H. / Abe, M. / Ikezono, Y. / Ueno, T. / Sata, M. et al. | 2013
- S131
-
314 IDENTIFICATION OF A NOVEL PROGENITOR CELL POPULATION IN THE INJURED ADULT MOUSE LIVER USING THE OVAL CELL MARKER Neighbor of Punc E 11Bowe, A. / Schievenbusch, S. / Curth, H. M. / Goeser, T. / Nierhoff, D. et al. | 2013
- S133
-
319 PATIENTS WITH COMPENSATED CIRRHOSIS HAVE SELECTIVE PARESIS OF FLAGELLIN-INDUCED INNATE IMMUNE RESPONSES DUE TO FAILURES IN ERK SIGNALLINGAlazawi, W. / Lahiri, R. / Spyrou, A. / Giles, E. / Bashir, Z. / OBrien, A. / Stagg, A. / Waters, J. / Foster, G. R. et al. | 2013
- S134
-
322 KIR AND HLA LOCI AS PREDICTORS OF HCC OUTCOME IN PATIENTS WITH HCV INFECTIONCariani, E. / Pilli, M. / Zerbini, A. / Rota, C. / Olivani, A. / Zanelli, P. / Zanetti, A. / Trenti, T. / Ferrari, C. / Missale, G. et al. | 2013
- S137
-
330 IMBALANCE BETWEEN CIRCULATING CD4+ REGULATORY T AND CONVENTIONAL T LYMPHOCYTES IN PATIENTS WITH HBV-RELATED ACUTE-ON-CHRONIC LIVER FAILUREDong, X. / Gong, Y. / Hao, Y. / Zeng, H. / Wang, X. / Shen, L. / Yang, S. / Chen, Y. / Meng, Q. / Li, H. et al. | 2013
- S138
-
331 CO-STIMULATION VIA CD27 MIGHT IMPORTANTLY CONTRIBUTE TO ANTI-HCV ACTIVITY OF NK CELLSEisenhardt, M. / Gl assner, A. / Kokordelis, P. / Kramer, B. / Wolter, F. / Boesecke, C. / Rockstroh, J. K. / Strassburg, C. P. / Spengler, U. / Nattermann, J. et al. | 2013
- S139
-
334 INTERACTION OF PROTECTIVE POLYMORPHISMS IN HCV: A COMPARISON OF SPONTANEOUS AND TREATMENT INDUCED RESOLUTIONHydes, T. / Ashraf, S. / Alexander, G. / Khakoo, S. et al. | 2013
- S140
-
337 EXPRESSION OF PD-1 AND CTLA-4 IS INCREASED DURING SYMPTOMATIC PHASE OF ACUTE HEPATITIS AKim, C. W. / Cho, H. / Kim, H. Y. / Lee, S. W. / Jang, J. W. / Choi, J. Y. / Yoon, S. K. / Lee, C. D. et al. | 2013
- S142
-
342 INTRAHEPATIC IL-8 PRODUCING CD4+ REGULATORY T CELLS AND FIBROGENESIS IN CHRONIC HEPATITIS CLanghans, B. / Arndt, S. / Braunschweiger, I. / Kramer, B. / Huneburg, R. / Manekeller, S. / Sauerbruch, T. / Spengler, U. et al. | 2013
- S143
-
345 PERSISTENT HEPATITIS C VIRUS (HCV) INFECTION IMPAIRS HCV-SPECIFIC CYTOTOXIC T CELL REACTIVITY THROUGH Mcl-1/Bim IMBALANCE DUE TO CD127 DOWN-REGULATIONLarrubia, J. R. / Lokhande, M. U. / Garcia-Garzon, S. / Miquel, J. / Gonzalez-Praetorious, A. / Sanz-de-Villalobos, E. et al. | 2013
- S144
-
347 REPETITIVE ACTIVATION OF TOLL-LIKE RECEPTOR 3 IN PRIMARY HUMAN HEPATOCYTES LEADS TO HYPER-RESPONSIVENESS TO POLY I:C IN VITROBroering, R. / Lutterbeck, M. / Trippler, M. / Paul, A. / Kleinehr, K. / Gerken, G. / Schlaak, J. F. et al. | 2013
- S145
-
350 FERROPORTIN 1 IS A "NUCLEAR" NEGATIVE ACUTE-PHASE PROTEIN IN RAT LIVER: A COMPARISON WITH OTHER IRON-TRANSPORT PROTEINSNaz, N. / Malik, I. A. / Ahmad, S. / Sheikh, N. / Ramadori, G. et al. | 2013
- S146
-
353 RNA SEQUENCING ANALYSIS OF HUMAN LIVER SINUSOIDAL ENDOTHELIAL CELLS REVEALS EVIDENCE FOR AN ANTI-INFLAMMATORY ROLE DURING HCV INFECTIONPapic, N. / Delker, D. / Liu, S. / Rong, X. / Vince, A. / Hagedorn, C. et al. | 2013
- S147
-
356 IgG4 IMMUNOSTAINING IN LIVER ALLOGRAFTS OF HEPATITIS C INFECTED PATIENTS WITH PLASMA CELL HEPATITIS - A POTENTIAL SURROGATE MARKER OF ALTERED AUTOIMMUNE PHENOMENASalomao, M. / Moreira, R. K. / Lefkowitch, J. H. / Bao, F. et al. | 2013
- S149
-
361 REGULATORY T-CELLS DIFFERENTIALLY REGULATE PROLIFERATION AND CYTOKINE PRODUCTION OF HCC-SPECIFIC CD8+ T-CELLSFlecken, T. / Schmidt, N. / Price, D. A. / Drognitz, O. / Schemmer, P. / Neumann-Haefelin, C. / Thimme, R. et al. | 2013
- S150
-
364 MODULATION OF LIVER FIBROSIS BY REGULATING ALTERNATIVELY ACTIVATED MACROPHAGE SIGNALING THROUGH IL-4RalphaWeng, S. Y. / Padberg, K. / Kim, Y. O. / Wang, X. Y. / McCaleb, M. / Schuppan, D. et al. | 2013
- S153
-
372 HIERARCHY OF INHIBITORY RECEPTOR EXPRESSION BY HEPATITIS B VIRUS (HBV)-SPECIFIC CD8+ T CELLS IN CHRONIC HBV INFECTIONBengsch, B. / Seigel, B. / Blum, H. E. / Thimme, R. et al. | 2013
- S154
-
375 CELL CYCLE ARREST AND MODULATION OF HBV REPLICATION IN POST TRANSCRIPTIONAL PROCESS BY miRNA-125bDeng, W. et al. | 2013
- S155
-
378 HEPATITIS B CORE (HBC) PROTEIN IS A KEY AND VERY EARLY NEGATIVE REGULATOR OF THE INTERFERON RESPONSEGruffaz, M. / Testoni, B. / Luangsay, S. / Ait-Goughoulte, M. / Petit, M. A. / Ma, H. / Klumpp, K. / Javanbakht, H. / Durantel, D. / Zoulim, F. et al. | 2013
- S156
-
380 RAPAMYCIN MODULATES THE COURSE OF HEPATITIS B VIRUS (HBV) INFECTION IN HYDRODYNAMIC INJECTION MOUSE MODEL: THE ROLE OF Treg IN HBV PERSISTENCEHuang, S. / Song, Z. / Wang, B. / Wang, J. / Zhu, Z. / Zhu, B. / Feng, X. / Lu, M. / Yang, D. et al. | 2013
- S157
-
382 SERUM INTERLEUKIN-37 AND LIVER INJURY IN CHRONIC HEPATITIS B PATIENTS WITH HBeAg SEROCONVERSIONLi, C. / Zhao, P. W. / Cai, Y. J. / Jiang, Y. F. et al. | 2013
- S158
-
385 IMPACT OF A181T AND I233V MUTATIONS IN HEPATITIS B VIRUS POLYMERASE REVERSE-TRANSCRIPTASE ON VIRAL REPLICATION AND DRUG-RESISTANCEKwon, S. Y. / Ahn, S. H. / Park, E. S. / Kim, J. H. / Choe, W. H. / Kim, K. H. et al. | 2013
- S159
-
388 HEPATITIS B VIRUS X PROTEIN INDUCES TRANSCRIPTION OF HUMAN TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) GENE DEPENDS ON sp-1Li, Y. / Li, W. / Han, M. / Chen, D. / Chen, P. / Luo, X. / Ning, Q. et al. | 2013
- S161
-
393 HIGHER SERUM CONCENTRATION OF IL-17F IS ASSOCIATED WITH IMMUNE CONTROL OF HBV INFECTIONParfieniuk, A. / Jaroszewicz, J. / Swiderska, M. / Rogalska-Plonska, M. / Flisiak, R. et al. | 2013
- S162
-
396 STUDY OF HBV (RE)INFECTION IN THE COURSE OF LIVER TRANSPLANTATION IN HBV, HBV/HDV AND OCCULT HBV INFECTED PATIENTSPollicino, T. / Caccamo, L. / Donato, M. F. / Raffa, G. / Rossi, G. / Raimondo, G. et al. | 2013
- S164
-
400 NUCLEOSIDE ANALOGUES ALONE OR COMBINED WITH VACCINATION PREVENT WHV INFECTION AND INDUCE PROTECTIVE IMMUNITY: NEW STRATEGY FOR HBV POST-EXPOSURE PROPHYLAXISWang, B. / Zhu, Z. / Zhu, B. / Song, Z. / Huang, S. / Fan, W. / Tao, Y. / Wang, Z. / Wang, H. / Lu, M. et al. | 2013
- S165
-
403 MESENCHYMAL STEM CELLS EXPRESSING IFITM3 CAN CAUSE THE INHIBITION OF HEPATITIS B VIRUS REPLICATION IN VITROZheng, Y. B. / Lin, B. L. / Lin, C. S. / Liu, J. / Wu, Z. B. / Su, Y. J. / He, H. L. / Gao, Z. L. et al. | 2013
- S166
-
405 HARPE STUDY: PREVALENCE OF RENAL ABNORMALITIES IN CHRONIC HBV INFECTIONAmet, S. / Bronowicki, J. P. / Thabut, D. / Zoulim, F. / Bourliere, M. / Mathurin, P. / De Ledinghen, V. / Benhamou, Y. / Larrey, D. / Bruce, E. et al. | 2013
- S167
-
408 HBsAg AND IP-10 PLASMA LEVELS KINETICS DURING THERAPY WITH PEGYLATED INTERFERON AND CONSEQUENT THERAPY WITH NUCLEOS(T)IDE ANALOGUESBruce, M. / Horner, M. / Fletcher, I. / Shang, D. / Hughes, S. / Joshi, D. / Harrison, P. / Agarwal, K. / Carey, I. et al. | 2013
- S168
-
411 A NEW HBsAg/ANTI-HBs IMMUNE COMPLEX ASSAY PREDICTS HBeAG LOSS IN CHRONIC HEPATITIS B PATIENTSde Niet, A. / Zaaijer, H. L. / Klause, U. / Jansen, L. / Takkenberg, B. / Janssen, H. L. / Chu, T. / Petric, R. / Reesink, H. W. et al. | 2013
- S169
-
413 AGE AND THE INACTIVE HBsAg CARRIER STATE ARE PREDICTIVE OF HBsAg LOSS IN A "REAL-LIFE" COHORT OF PATIENTS WITH CHRONIC HBV INFECTIONHabersetzer, F. / Moenne-Loccoz, R. / Meyer, N. / Schvoerer, E. / Simo-Noumbissie, P. / Dritsas, S. / Stoll-Keller, F. / Fafi-Kremer, S. / Baumert, T. F. / Doffo el, M. et al. | 2013
- S170
-
416 PREDICTION OF ACTIVE HBV-CARRIER STATUS IN A COHORT OF EUROPEAN UNTREATED HBeAg NEGATIVE PATIENTS: A PROSPECTIVE LONGITUDINAL STUDYKnop, V. / Vermehren, J. / Wedemeyer, H. / Mauss, S. / Hueppe, D. / Petersen, J. / Welzel, T. / Buslau, A. / Gerber, L. / Friess, J. et al. | 2013
- S172
-
421 OCCULT HEPATITIS B VIRUS INFECTION AMONG HEPATOCELLULAR CARCINOMA PATIENTS IN JAPANMuto, J. / Mukaide, M. / Sugiyama, M. / Hiramine, S. / Takeda, T. / Aoki, T. / Matsui, T. / Nishida, N. / Imamura, M. / Korenaga, M. et al. | 2013
- S174
-
427 HIGH RATES OF HBsAg "a DETERMINANT" VARIABILITY AND IMMUNE ESCAPE MUTATIONS ARE ASSOCIATED WITH HBV REACTIVATION UPON IMMUNOSUPPRESSIVE THERAPYSalpini, R. / Alteri, C. / Cento, V. / Ricciardi, A. / Maffongelli, G. / Pollicita, M. / Mirabelli, C. / Sarrecchia, C. / Sarmati, L. / Mastroianni, C. et al. | 2013
- S176
-
432 TRANSFER OF HEPATITIS B SURFACE MARKERS AND HBVDNA FROM HEPATITIS B SURFACE ANTIGEN POSITIVE MOTHERS TO THEIR OFFSPRINGWang, J. / Zhao, Y. / Feng, Y. / Liu, H. / Song, H. / Yuan, N. / Du, D. / Feng, W. / Liu, J. / Yang, Y. et al. | 2013
- S178
-
437 THE IMPACT OF LONGITUDINAL ASSESSMENT OF LIVER STIFFNESS BY TRANSIENT ELASTOGRAPHY FOR CHRONIC HBeAg(-) PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUESKachagias, G. / Zacharakis, G. / Athanasopoulos, E. / Anastasiou, J. / Saprikis, E. / Viazis, N. / Karamanolis, D. et al. | 2013
- S180
-
441 TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS CBaran, B. / Gulluoglu, M. / Soyer, O. / Ormeci, A. / Gokturk, S. / Evirgen, S. / Yesil, S. / Akyuz, F. / Karaca, C. / Demir, K. et al. | 2013
- S181
-
443 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL3 AND ITS HLA-C LIGANDS DO NOT PREDICT SPONTANEOUS RESOLUTION IN PATIENTS WITH ACUTE HEPATITIS CBeinhardt, S. / Payer, B. A. / Datz, C. / Strasser, M. / Maieron, A. / Dorn, L. / Huber, F. / Dulic-Lakovic, E. / Stauber, R. / Laferl, H. et al. | 2013
- S182
-
446 ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENTCoppola, N. / Pisaturo, M. / Stanzione, M. / Messina, V. / Sagnelli, C. / Alessio, L. / Starace, M. / Pasquale, G. / Sagnelli, E. et al. | 2013
- S183
-
449 INCREASED IL28B PLASMA LEVEL IS ASSOCIATED WITH REDUCED IP-10, KLRD1 AND INCREASED MX1 EXPRESSION DURING CHRONICALLY EVOLVING ACUTE HCV INFECTIONDepla, M. / Brunaud, C. / Bruneau, J. / Shoukry, N. et al. | 2013
- S185
-
454 microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIAFognani, E. / Piluso, A. / Gragnani, L. / Giannini, C. / Caini, P. / Monti, M. / Ranieri, J. / Urraro, T. / Triboli, E. / Laffi, G. et al. | 2013
- S186
-
457 THE QUALITY OF LIVER SPECIMEN USING TWO DIFFERENT LARGE NEEDLE BIOPSY DEVICES: A PROSPECTIVE RANDOMIZED-CONTROLLED STUDYGarcovich, M. / Riccardi, L. / Vecchio, F. M. / Arena, V. / Pennacchia, I. / Pizzolante, F. / Grieco, A. / Gasbarrini, A. / Rapaccini, G. L. / Pompili, M. et al. | 2013
- S187
-
459 INSULIN RESISTANCE AND HIGH CHOLESTEROL LEVELS ARE ASSOCIATED WITH VITAMIN D DEFICIENCY IN HCV, HIV AND HIV/HCV COINFECTED PATIENTSGonzalez, M. P. / Klautau, G. B. / Mazo, D. F. / Nogueira, R. S. / Mendes-Correa, M. C. / Carrilho, F. J. / Pessoa, M. G. et al. | 2013
- S189
-
462 THE ASSOCIATION BETWEEN HAEMOGLOBIN DECLINE AND SVR IS INDEPENDENT OF ITPA GENOTYPE DURING PEG-INTERFERON PLUS RIBAVIRIN THERAPY FOR HCV-1: ANALYSIS FROM THE CHARIOT STUDYHolmes, J. A. / Bonanzinga, S. / Roberts, S. K. / Sievert, W. / Dore, G. J. / McCaughan, G. / Crawford, D. H. / Cheng, W. S. / Weltman, M. D. / Matthews, G. et al. | 2013
- S191
-
467 COST IMPLICATIONS OF ONE-TIME HCV SCREENING OF THE 1945 TO 1965 BIRTH COHORT IN BRITISH COLUMBIA, CANADAKrajden, M. / Cook, D. / Buller-Taylor, T. / Butt, G. / Yu, A. et al. | 2013
- S193
-
472 HEPATOCELLULAR MxA PROTEIN EXPRESSION IS A POWERFUL PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C GENOTYPE 1 INFECTION USING A MULTIVARIATE LOGISTIC REGRESSION MODELMessineo, A. / Duffy, S. / Huang, Y. / Platten, M. / De Boer, B. / Jeffrey, G. / Mac Quillan, G. et al. | 2013
- S194
-
475 THE INFLUENCE OF PORTAL PRESSURE ON THE DISCORDANCE OF ABSOLUTE CD4+ COUNT AND CD4+ PERCENTAGE IN HIV/HCV COINFECTED PATIENTSMandorfer, M. / Reiberger, T. / Payer, B. A. / Ferlitsch, A. / Breitenecker, F. / Aichelburg, M. C. / Rieger, A. / Trauner, M. / Peck-Radosavljevic, M. et al. | 2013
- S195
-
477 PERSISTENCE OF HEPATITIS C VIRUS DURING AND AFTER CLINICALLY APPARENT SUCCESSFUL TREATMENT OF CHRONIC HEPATITIS CChen, A. Y. / Zeremski, M. / Jacobson, I. M. / Talal, A. H. / Michalak, T. I. et al. | 2013
- S196
-
480 FAVOURABLE IL28B GENOTYPES AND LIVER FIBROSIS IN HIV/HEPATITIS C (HCV) CO-INFECTED INDIVIDUALS FROM THE CANADIAN CO-INFECTION COHORTMoqueet, N. / Lisle, C. / Carter, R. / Platt, R. / Hull, M. / Cooper, C. / Walmsley, S. / Potter, M. / Klein, M. B. et al. | 2013
- S198
-
484 IMPACT OF LIVER FIBROSIS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS TREATED WITH ANTIVIRAL THERAPY: LONG TERM FOLLOW UP STUDYPellicelli, A. M. / Vignally, P. / Romano, M. / Miglioresi, L. / Mazzoni, E. / Mecenate, F. / Bonaventura, M. E. / Villani, R. / Dambrosio, C. / Fondacaro, L. et al. | 2013
- S199
-
487 LONG TERM SURVIVAL OF LIVER FIBROSIS AFTER VIROLOGICAL CURE (SVR) IN HIV-HCV COINFECTED PATIENTS: A WORRISOME LATENT DISEASE?Poynard, T. / Valantin, M. A. / Munteanu, M. / Moussalli, J. / Thabut, D. / Lebray, P. / Rudler, M. / Ngo, Y. / Thibault, V. / Charlotte, F. et al. | 2013
- S200
-
490 INFLUENCE OF PREDICTOR VARIABLES ON QUALITY OF LIFE OF PATIENTS WITH CHRONIC VIRAL HEPATITIS CSargsyants, N. et al. | 2013
- S201
-
491 MINIMAL NEUROPSYCHOMOTOR DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS CSavlan, I. / Valantinas, J. / Audronyte, E. / Aksionova, D. / Liakina, V. et al. | 2013
- S203
-
496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPYBarreiro, P. / Labarga, P. / Fernandez-Montero, J. V. / Poveda, E. / de Mendoza, C. / Sanchez, C. / Vispo, E. / Soriano, V. et al. | 2013
- S204
-
499 VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1Takaguchi, K. / Toyota, H. / Seno, T. / Baba, N. / Nagano, T. / Kumada, T. / Kato, K. / Shimada, N. / Ide, T. / Sata, M. et al. | 2013
- S205
-
501 PATIENT CHARACTERISTICS AND UTILIZATION OF PROTEASE INHIBITORS IN HEPATITIS C (HCV) PATIENTS IN A LARGE PAYER DATABASETandon, N. / Gunnarsson, C. / Prabhakar, A. et al. | 2013
- S206
-
503 HCV NEUTRALIZING ANTIBODY RESPONSE DURING SPONTANEOUS AND TREATMENT-INDUCED VIRAL CLEARANCE OF ACUTE HCV INFECTION IN HIV-INFECTED MSMThomas, X. V. / Molenkamp, R. / Koekkoek, S. M. / van der Meer, J. T. / Prins, M. / Merat, S. / Beaumont, T. / Schinkel, J. et al. | 2013
- S207
-
505 DONOR IL28B TT-POLYMORPHISM IS ASSOCIATED WITH INCREASED INCIDENCE OF HEPATIC STEATOSIS IN LIVER TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS CVeldt, B. J. / Duarte-Rojo, A. / Thompson, A. J. / Heimbach, J. K. / Janssen, H. L. / Tillmann, H. L. / Goldstein, D. D. / McHutchison, J. G. / Charlton, M. R. et al. | 2013
- S209
-
510 DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS WHO ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO INTERFERON THERAPYYamashita, N. / Yamasaki, A. / Oho, A. / Kajiwara, E. et al. | 2013
- S210
-
513 CCL20 AS POTENTIAL MEDIATOR OF INFLAMMATION AND FIBROSIS IN PATIENTS WITH ALCOHOLIC HEPATITIS: EVIDENCES OF A TRANSLATIONAL STUDYAffo, S. / Morales-Ibanez, O. / Rodrigo-Torres, D. / Altamirano, J. / Dapito, D. H. / Caviglia, J. M. / Arroyo, V. / Gines, P. / Caballeria, J. / Schwabe, R. F. et al. | 2013
- S212
-
518 THE SPANISH-LATIN AMERICAN DILI NETWORK: PRELIMINARY RESULTS FROM A COLLABORATIVE STRATEGIC INITIATIVEBessone, F. / Hernandez, N. / Sanchez, A. / di Pace, M. / Arrese, M. / Brahm, J. R. / Ruiz, A. / Arancibia, J. / Kershenobich, D. / Loaeza del Castillo, A. et al. | 2013
- S214
-
523 CD14+CD16+ MONOCYTES ARE EXPANDED IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS AND CHARACTERISED BY HIGH EXPRESSION OF INTERLEUKIN 10Dhanda, A. / Liu, B. / Lee, R. / Collins, P. et al. | 2013
- S216
-
528 INCREASED HEPCIDIN SECRETION BY INFLAMMATORY CYTOKINES IN PATIENTS WITH ALCOHOLIC LIVER DISEASEFujita, N. / Miyachi, H. / Sugimoto, R. / Moroka, R. / Tanaka, H. / Iwasa, M. / Tomosugi, N. / Takei, Y. et al. | 2013
- S217
-
531 DEVELOPMENT OF DECOMPENSATED ALCOHOLIC LIVER DISEASE (ALD) IS ASSOCIATED WITH STARTING HEAVY DRINKING AT AN OLDER AGE: A CASE-CONTROL STUDYGleeson, D. / Ali, A. K. / Jones, J. S. / Bradley, M. P. / Peck, R. J. / McCormack, K. M. et al. | 2013
- S218
-
534 MUSCLE GLUTAMINE SYNTHASE REGULATES THE SEVERITY OF HYPERAMMONEMIA, HEPATIC INFLAMMATION, BRAIN SWELLING AND SURVIVAL IN ACETAMINOPHEN HEPATOTOXICITYJover-Cobos, M. / Davies, N. A. / Adebayo, D. / Habtesion, A. / Baker, L. A. / Shah, N. / Sharifi, Y. / Mookerjee, R. / Jalan, R. et al. | 2013
- S219
-
536 SHORT-TERM SURVIVAL IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH PENTOXIFYLLINE vs. CORTICOSTEROID: A NON-INFERIORITY TRIAL - A PRELIMINARY REPORTKim, D. J. / Suk, K. T. / Park, S. H. / Tak, W. Y. / Yim, H. J. / Um, S. H. / Yoon, K. T. / Kim, Y. S. / Lee, H. J. / Baik, S. K. et al. | 2013
- S220
-
539 DRUG-INDUCED LIVER INUJRY: THE IMPACT OF NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)Licata, A. / Butera, G. / Maida, M. / Calvaruso, V. / Cappello, M. / Craxi, A. / Almasio, P. L. et al. | 2013
- S221
-
541 SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS: A NOVEL ROLE FOR PD-1 AND GALECTIN-9?Markwick, L. J. / Ryan, J. M. / Palma, E. / Cooksley, H. / Tranah, T. H. / Vergis, N. / Williams, R. / Evans, A. / Shawcross, D. L. / Chokshi, S. et al. | 2013
- S222
-
544 THE DISCOVERY OF BETTER BIOMARKERS OF DRUG INDUCED LIVER INJURY (DILI) NEEDS TO USE OTHER ENDPOINTS THAN ALT. A PILOT PROOF OF CONCEPT STUDYPerazzo, H. / Merz, M. / Poynard, T. et al. | 2013
- S223
-
547 DOWN-REGULATION OF TOLL-LIKE RECEPTOR-2 AND -4 IN CIRCULATING NEUTROPHILS IN RESPONSE TO SYSTEMIC OXIDATIVE STRESS MAY CONTRIBUTE TO INCREASED SUSCEPTIBILITY TO INFECTION IN ALCOHOLIC HEPATITISRyan, J. M. / Mannakat Vijay, G. K. / Thomas, T. H. / Markwick, L. / Abeles, R. D. / Vergis, N. / Blackmore, L. J. / Taylor, N. J. / Chokshi, S. / OGrady, J. et al. | 2013
- S224
-
549 INHIBITION OF p53 MITIGATES ETHANOL-INDUCED TIGAR UPREGULATION, REDUCTIVE STRESS AND SUBSEQUENTLY IMPROVES HEPATIC INSULIN SIGNALING IN THE LIVERS OF ETHANOL-FED LONG-EVANS RATSDerdak, Z. / Sousa, A. / Wu, A. / Wands, J. et al. | 2013
- S225
-
552 CIRCULATING NEUTROPHIL GRANULE SUBSET RELEASE IN RESPONSE TO BACTERIAL STIMULUS IS AUGMENTED IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE AND MAY CONTRIBUTE TO ORGAN BYSTANDER DAMAGETranah, T. H. / Manakkat Vijay, G. K. / Ryan, J. M. / Abeles, R. D. / Markwick, L. J. / Chana, P. J. / Shawcross, D. L. et al. | 2013
- S229
-
558 HCV KINETICS DURING AND AFTER THE ANHEPATIC PHASE: IS THE LIVER THE PRIMARY SITE FOR HCV CLEARANCE?Chung, T. L. / Crespo, G. / Mensa, L. / Perez-del-Pulgar, S. / Navasa, M. / Cotler, S. J. / Forns, X. / Dahari, H. et al. | 2013
- S230
-
560 OAS AND IL-28b GENETIC POLYMORPHISMS IN RELATION TO HCV RECURRENCE POST LIVING RELATED LIVER TRANSPLANTATIONAbdel Aziz, A. / Elbaz, T. / Ryad, M. / El Awady, M. et al. | 2013
- S231
-
563 A NOVEL RECOMBINANT FORM OF THE HUMAN MANGANESE SUPEROXIDE DISMUTASE PROTECTS RAT LIVER GRAFTS PROCURED FOR TRANSPLANTATIONHide, D. / Guixe-Muntet, S. / Mancini, A. / Bosch, J. / Gracia- Sancho, J. et al. | 2013
- S232
-
566 STUDY OF HEPATITIS C VIRUS SUPERINFECTION AFTER LIVER TRANSPLANTATION BY ULTRA-DEEP PYROSEQUENCINGPerez-del-Pulgar, S. / Gregori, J. / Gonzalez, P. / Garcia-Cehic, D. / Ramirez, S. / Cubero, M. / Esteban, J. I. / Forns, X. / Quer, J. et al. | 2013
- S233
-
569 HUMAN-SCALE TRANSPLANTABLE LIVER GRAFT USING DECELLULARIZED WHOLE-ORGAN SCAFFOLDYagi, H. / Soto-Gutierrrez, A. / Hibi, T. / Abe, Y. / Tanaka, K. / Kitago, M. / Obara, H. / Itano, O. / Tanabe, M. / Kitagawa, Y. et al. | 2013
- S234
-
572 THE EFFECT OF AMMONIUM ON EXTRACELLULAR LACTATE, GLUTAMATE, AND ADENOSINE IN CORTEX OF RAT BRAIN SLICES. A BIOSENSOR DOSE-RESPONSE STUDYBjerring, P. N. / Dale, N. / Larsen, F. S. et al. | 2013
- S236
-
577 ASSESSMENT OF ADRENAL FUNCTION IN PATIENTS WITH STABLE DECOMPENSATED CIRRHOSIS USING SALIVARY AND TOTAL SERUM CORTISOLCholongitas, E. / Goulis, J. / Kokonis, G. / Nakouti, T. / Rakitzi, P. / Chalevas, P. / Slavakis, A. / Akriviadis, E. et al. | 2013
- S239
-
585 GLUTAMINE SYNTHESIS IS ESSENTIAL FOR AMMONIA DETOXIFICATION TO UREAHakvoort, T. B. / He, Y. / Lamers, W. H. et al. | 2013
- S242
-
593 LENALIDOMIDE AMELIORATES THE PORTAL HYPERTENSIVE SYNDROME IN NON-CIRRHOTIC AND CIRRHOTIC PORTAL HYPERTENSIVE ANIMALSPayer, B. / Reiberger, T. / Schwabl, P. / Horvatits, T. / Fuhrmann, V. / Angermayr, B. / Peck-Radosavljevic, M. et al. | 2013
- S243
-
596 TARGETING OF LYSYL OXIDASE-LIKE-2 (LOXL2) PROMOTES REVERSAL OF LIVER FIBROSIS VIA INHIBITION OF COLLAGEN CROSS-LINKING AND FIBROTIC MATRIX STABILIZATIONIkenaga, N. / Yoshida, S. / Liu, S. B. / Chung, J. / Sverdlov, D. / Marshall, D. / Smith, V. / Kovalenko, M. / Karnik, S. / Afdhal, N. et al. | 2013
- S244
-
598 IN VITRO EFFECT OF n-6/n-3 POLYUNSATURATED FATTY ACIDS ON PLATELET NOX2-MEDIATED OXIDATIVE STRESS IN LIVER CIRRHOSISRaparelli, V. / Napoleone, L. / Riggio, O. / Merli, M. / Angelico, F. / Del Ben, M. / Proietti, M. / Carnevale, R. / Pignatelli, P. / Basili, S. et al. | 2013
- S245
-
601 miR-133a MEDIATES TGF-b-DEPENDENT DE-REPRESSION OF COLLAGEN-SYNTHESIS IN HEPATIC STELLATE CELLS DURING LIVER FIBROSISRoderburg, C. / Cardenas, D. V. / Hellerbrand, C. / Zimmermann, H. / Tacke, F. / Trautwein, C. / Luedde, T. et al. | 2013
- S246
-
604 THE INFLUENCE OF SPLENECTOMY ON HEMODYNAMIC AND HEMATOLOGICAL ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC PORTAL HYPERTENSIVE RATSSchwabl, P. / Payer, B. A. / Schubert, T. L. / Riedl, F. / Wagner, M. / Garnys, L. / Schiefer, A. I. / Reiberger, T. / Peck-Radosavljevic, M. et al. | 2013
- S247
-
606 CYTOKINE PRODUCTION IN PATIENTS WITH CIRRHOSIS AND D299G AND/OR T399I TOLL-LIKE RECEPTOR 4 POLYMORPHISMSSoriano, G. / Sanchez, E. / Nieto, J. C. / Roman, E. / Vidal, S. / Oliva, L. / Guarner-Argente, C. / Poca, M. / Torras, X. / Juarez, C. et al. | 2013
- S248
-
608 GENE-EXPRESSION PROFILING REVEALS AN UNEXPECTED DEFECT IN INDUCTION OF INTERFERON TARGET GENES IN LPS-STIMULATED IMMUNE CELLS FROM CIRRHOTIC PATIENTSWeiss, E. / Fasseu, M. / Rautou, P. E. / Elkrief, L. / Paugam-Burtz, C. / Valla, D. / Lebrec, D. / Moreau, R. et al. | 2013
- S250
-
613 USEFULNESS OF ACTIVE BLEEDING AS PROGNOSTIC FACTOR IN CHILD-PUGH B CIRRHOTIC PATIENTS WITH ACUTE VARICEAL BLEEDING. IS EARLY TIPS JUSTIFIED?Castellote, J. / Girbau, A. / Rota, R. / nas, E. D. / Baliellas, C. / Xiol, X. et al. | 2013
- S251
-
616 ECONOMIC EVALUATION OF EARLY TIPS PROCEDURES WITH EPTFE COVERED STENT-GRAFTS CONFIGURED FOR TIPS COMPARED TO ENDOSCOPIC PROCEDURES TO MANAGE ACUTE VARICEAL BLEEDINGBurke, M. / Hacking, N. / Wright, M. / Iqbal, K. / Craig, J. et al. | 2013
- S253
-
620 IS THE DIAGNOSIS OF IDIOPATHIC NON-CIRRHOTIC PORTAL HYPERTENSION BE CONSIDERED IN PATIENTS WITH PRIMARY ANTIBODY DEFICIENCIES?Pentassuglio, I. / Pulvirenti, F. / Onori, E. / Gioia, S. / Pasquale, C. / Nardelli, S. / Merli, M. / Quinti, I. / Riggio, O. et al. | 2013
- S256
-
628 ANALYSIS OF miRNA EXPRESSION PATTERNS OF HUMAN AND MOUSE HEPATOCELLULAR CARCINOMA (HCC) SAMPLESBaek, S. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Han, K. H. / Ro, W. S. et al. | 2013
- S257
-
631 HEPATOCELLULAR CARCINOMA (HCC) AND METABOLIC SYNDROME: CLINICAL, BIOLOGICAL, PATHOLOGICAL FEATURES AND PROGNOSIS. ANALYSIS OF A PROSPECTIVE COHORT OF 925 HCCLe Cleach, A. / Possenti, L. / Blanc-Bisson, C. / Laurent, C. / Trillaud, H. / Le-Bail, B. / Bioulac-Sage, P. / Balabaud, C. / Blanc, J. F. et al. | 2013
- S258
-
633 A NOVEL APPROACH TO IMAGE ANALYSIS FOR HEPATIC ONCOLOGY DIAGNOSIS BASED ON FRACTAL GEOMETRY. PRELIMINARY RESULTSBubnov, R. / Melnyk, I. M. et al. | 2013
- S260
-
639 CYTOKERATIN 18 AS A POTENTIAL MARKER PREDICTS EARLY LOCAL RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER CURATIVE LOCAL ABLATIONElalfy, H. / Basheer, T. / El-Hussiny, M. A. / Alsayed, S. A. / Alhaware, G. et al. | 2013
- S261
-
642 ASSOCIATION BETWEEN EPIDERMAL GROWTH FACTOR GENE 61AG POLYMORPHISM AND AGE AT THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: IMPLICATIONS FOR SURVEILLANCESmirne, C. / Franzosi, L. / Magri, A. / Boccato, E. / Mossio, E. / Marconi, C. / Minisini, R. / Pirisi, M. et al. | 2013
- S262
-
645 OUTCOME OF HEPATITIS B AND C VIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA OCCURRING AFTER RENAL TRANSPLANTATIONKanaan, N. / Raggi, C. / Goffin, E. / Hassoun, Z. et al. | 2013
- S263
-
647 IMMUNOHISTOCHEMICAL REAPPRAISAL OF HEPATOCELLULAR ADENOMAS: A SINGLE INSTITUTION EXPERIENCE OF 61 PATIENTS IN THE UNITED STATESHernandez-Prera, J. C. / Elsabbagh, A. / Ward, S. C. / Fiel, M. I. / Roayaie, S. / Schwartz, M. E. / Thung, S. N. et al. | 2013
- S265
-
653 IMPACT OF HIGHLY EFFECTIVE ANTIVIRAL THERAPY ON THE BURDEN OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C CIRRHOSISKim, W. R. / Congley, S. E. / Roberts, L. R. / Gores, G. J. et al. | 2013
- S266
-
655 SERUM MICROPARTICLES (MP) AS A NOVEL TOOL TO IDENTIFY HEPATOCELLULAR CARCINOMA (HCC)Kornek, M. / Lynch, M. / Afdhal, N. H. / Schuppan, D. et al. | 2013
- S267
-
658 microRNA PROFILE IN CHRONIC HEPATITIS B RELATED HEPATOCELLULAR CARCINOMA: OVEREXPRESSION OF microRNA-224 IN HEPATOCELLULAR CARCINOMA TISSUE CAN PREDICT RECURRENCE AFTER CURATIVE RESECTIONLee, S. J. / Yeon, J. E. / Kim, H. R. / Kang, K. H. / Kang, S. H. / Lee, H. J. / Yoon, E. L. / Suh, S. J. / Kim, J. H. / Seo, Y. S. et al. | 2013
- S269
-
663 THE ROLE OF HISTOLOGY IN THE PROGNOSIS OF LIVER ADENOMATOSISWillandt, B. / Roskams, T. / Verslype, C. / Aerts, R. / Topal, B. / Laleman, W. / Cassiman, D. / Van der Merwe, S. / Van Steenbergen, W. / Nevens, F. et al. | 2013
- S272
-
671 CLINICAL FEATURES OF NON ALCOHOLIC STEATOHEPATITIS (NASH)-RELATED HEPATOCELLULAR CARCINOMA (HCC) IN ITALY: A MULTICENTER PROSPECTIVE SURVEYRossini, A. / Sacco, R. / Fornari, F. / De Sio, I. / Spinzi, G. / Francica, G. / Parisi, G. / Salmi, A. / Dionigi, E. / Farinati, F. et al. | 2013
- S273
-
674 INSULIN INCREASES THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSISSingh, S. / Singh, P. P. / Singh, A. G. / Murad, M. H. / Sanchez, W. et al. | 2013
- S276
-
681 ASSOCIATION OF POLYMORPHISMS OF TUMOR NECROSIS FACTOR LOCUS WITH DISEASE SEVERITY AND INCREASED HEPATOCELLULAR CARCINOMA RISKTsai, J. F. / Lin, Z. Y. / Chen, S. C. / Chuang, W. L. / Wang, L. Y. / Yu, M. L. / Dai, C. Y. et al. | 2013
- S278
-
686 PROGRESSION AND PATHOGENESIS ROLE OF RNA BINDING PROTEIN La-RELATED PROTEIN 1 IN HEPATOCELLULAR CARCINOMASXie, C. / Zhang, Q. S. / Xie, J. Q. / Peng, L. / Zhang, G. L. / Xie, D. Y. / Gao, Z. L. et al. | 2013
- S279
-
689 THE HUMAN DEVELOPMENT INDEX IS ASSOCIATED WITH THE GLOBAL INCIDENCE AND MORTALITY RATES OF LIVER CANCERHu, Q. D. / Zhang, Q. / Chen, W. / Liang, T. B. et al. | 2013
- S280
-
691 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDYArena, R. / Azzaroli, F. / Montagnani, M. / Simoni, P. / Colliva, C. / Calvanese, C. / Lisotti, A. / Cecinato, P. / Buonfiglioli, F. / Belvisi, S. et al. | 2013
- S281
-
694 LYSYL OXIDASE-LIKE 2 (LOXL2) PROTEIN IS INDUCED IN HUMAN CHOLESTATIC LIVER DISEASE AND IN ANIMAL MODELS OF CHOLANGIOPATHIESPollheimer, M. J. / Bowlus, C. / Lackner, C. / Karlsen, T. H. / Hov, J. R. / Lyman, S. / Adamkewicz, J. / Mikels-Vigdal, A. / Marshall, D. / Smith, V. et al. | 2013
- S282
-
696 BILE SALTS REGULATE THEIR SYNTHESIS BY INDUCING NITRIC OXIDE (NO) PRODUCTION IN HEPATOCYTES ALLOWING NITROSYLATION AND FUNCTIONALITY OF Cyp7a1 REPRESSOR COMPLEX PROTEINSRodriguez-Ortigosa, C. M. / Celay, J. / Juanarena, N. / Arcelus, S. / Medina, J. F. / Prieto, J. et al. | 2013
- S283
-
699 PROFOUND SELECTIVE REPRESSION OF Abcg5 LEADS TO MINOR CHANGES IN HEPATIC CHOLESTEROL SECRETION RATESKrawczyk, M. / Bohner, A. / Lammert, F. / Weber, S. et al. | 2013
- S285
-
703 QUANTITATIVE MAGNETIC RESONANCE IMAGING (MRI) IN THE EVALUATION OF THE DEGREE OF STEATOSIS, IRON ACCUMULATION AND FIBROSIS IN CHRONIC LIVER DISEASE (MRker STUDY)Hoad, C. L. / Palaniyappan, N. / Kaye, P. / Stephenson, M. / Bawden, S. / Dolman, G. / James, M. W. / Costigan, C. / Austin, A. / Chernova-Chernaya, Y. et al. | 2013
- S287
-
708 FACTORS INFLUENCING FAILURE OF LIVER STIFFNESS MEASUREMENTS USING TRANSIENT ELASTOGRAPHY - MONOCENTRIC EXPERIENCESirli, R. / Sporea, I. / Jurchis, A. / Bota, S. / Deleanu, A. / Dan, I. / Ardelean, M. / Cornu, N. / Popescu, A. / Danila, M. et al. | 2013
- S288
-
710 TIMP-1 IN PATIENTS WITH CIRRHOSIS: RELATION TO LIVER DYSFUNCTION, PORTAL HYPERTENSION, AND HAEMODYNAMIC CHANGESBusk, T. M. / Bendtsen, F. / Jensen, V. / Nielsen, H. J. / Brunner, N. / Moller, S. et al. | 2013
- S289
-
713 IMPROVEMENT OF TRANSIENT ELASTOGRAPHY APPLICABILITY TO EVALUATE LIVER STIFFNESS BY TRAINED OPERATORS AND USING XL PROBECarrion, J. A. / Puigvehi, M. / Coll, S. / Garcia-Retortillo, M. / Canete, N. / Cirera, I. / Gimenez, M. D. / Marquez, C. / Bory, F. / Sola, R. et al. | 2013
- S290
-
715 NON-INVASIVE CHOLATE TESTING PREDICTS RESPONSE TO PEGINTERFERON/RIBAVIRIN AND MEASURES FUNCTIONAL IMPROVEMENT AFTER SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS CHelmke, S. / Desanto, J. / Herman, A. / Lauriski, S. / Everson, G. et al. | 2013
- S293
-
723 RISK ASSESSMENT OF LIVER-RELATED EVENTS DEVELOPMENT USING TRANSIENT ELASTOGRAPHY IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING ENTECAVIRKim, M. N. / Kim, S. U. / Park, J. Y. / Kim, D. Y. / Han, K. H. / Chon, C. Y. / Ahn, S. H. et al. | 2013
- S294
-
726 VIRTUAL TOUCH TISSUE QUANTIFICATION FOR NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS BLiu, Y. X. / Dong, C. F. / Yang, G. L. / Li, H. Y. / Yao, S. M. / Lin, Y. M. / Yuan, J. / Zhou, B. P. et al. | 2013
- S295
-
729 VARIABLES RELATED TO INADEQUATE LIVER STIFFNESS MEASUREMENTS USING TRANSIENT ELASTOGRAPHY. ANALYSIS OF 895 EXAMINATIONSPuigvehi, M. / Carrion, J. A. / Coll, S. / Garcia-Retortillo, M. / Canete, N. / Cirera, I. / Gimenez, M. D. / Marquez, C. / Bory, F. / Sola, R. et al. | 2013
- S297
-
734 LIVER STIFFNESS BY SHEAR WAVE ELASTOGRAPHY IS INFLUENCED BY MEAL AND MEAL-RELATED HAEMODYNAMIC MODIFICATIONSVonghia, L. / Verlinden, W. / Pelckmans, P. / Michielsen, P. / Francque, S. et al. | 2013
- S298
-
736 NOVEL EFFECTOR OF HBV CAPSID ASSEMBLY REDUCES THE ACTIVITY OF cccDNA AND INTERACTS SYNERGISTICALLY WITH NUCLEOSIDE ANALOGS IN THE HUMAN HEPATOCYTESBassit, L. / Ozturk, T. / Tao, S. / Boucle, S. R. / Ehteshami, M. / Zlotnick, A. / Feitelson, M. A. / Schinazi, R. F. et al. | 2013
- S300
-
741 OPTIMIZED STRATEGY: SEQUENTIAL PEGYLATED INTERFERON a-2a THERAPY IN ENTECAVIR-TREATED PATIENTS CHB WITHOUT SATISFACTORY END-POINT LED TO HBeAg SEROCONVERSIONChen, X. F. / Chen, X. P. / Ma, X. J. / Chen, W. L. et al. | 2013
- S301
-
744 TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENTFung, S. / Kwan, P. / Horban, A. / Pelemis, M. / Husa, P. / Hann, H. W. / Flaherty, J. / Massetto, B. / Dinh, P. / Custodio, J. et al. | 2013
- S303
-
749 EFFICACY AND SAFETY OF PEGINTERFERON alfa-2a (40KD) IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS PARTICIPATING IN A RESPONSE-GUIDED THERAPY STUDY: AN INTERIM ANALYSIS AT WEEK 72Hou, J. / Ma, H. / Sun, J. / Xie, Q. / Xie, Y. / Sun, Y. / Wang, H. / Shi, G. / Wan, M. / Niu, J. et al. | 2013
- S304
-
751 IS HBV-RELATED RENAL TUBULOPATHY BEFORE ANY ANTIVIRAL TREATMENT A REALITY?Jacques, J. / Essig, M. / Carrier, P. / Debette-Gratien, M. / Saint-Marcoux, F. / Chianea, T. / Rousseau, A. / Alain, S. / Legros, R. / Sarabi, M. et al. | 2013
- S306
-
755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAIVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICSLampertico, P. / Soffredini, R. / Vigano, M. / Minola, E. / Cologni, G. / Rizzi, M. / Zaltron, S. / Vavassori, A. / Castelli, F. / Angeli, E. et al. | 2013
- S307
-
757 ADDING PEGINTERFERON alfa-2a ON NUCLEOS(T)IDE ANALOGUES THERAPY IMPROVES HBeAg SEROCONVERSION AND qHBsAg DECLINE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS WHO HAVE ACHIEVED VIROLOGICAL RESPONSESLi, Q. / Dong, G. / Yu, J. / Sun, C. / Xie, S. et al. | 2013
- S308
-
759 IMPACT OF ENTECAVIR VERSUS LAMIVUDINE ON HEPATIC COVALENTLY CLOSED-CIRCULAR DNA AND TOTAL HEPATIC HBVDNA IN NUCLEOSIDE-NAIVE HBeAg POSITIVE CHRONIC HEPATITIS B PATIENTSBowden, S. / Locarnini, S. / Chang, T. T. / Chao, Y. C. / Han, K. H. / Gish, R. G. / de Man, R. / Llamoso, C. / Tang, H. et al. | 2013
- S309
-
761 COMPARISON OF SERUM HBsAg DECLINES DURING TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN DIFFERENT CHRONIC HEPATITIS B (CHB) SUB-POPULATIONSChan, H. L. / Buti, M. / Marcellin, P. / Lin, L. / Massetto, B. / Flaherty, J. / Subramanian, M. / McHutchison, J. / Foster, G. / Fung, S. et al. | 2013
- S310
-
763 ENTECAVIR EFFECT ON LIVER FUNCTION IN FIELD PRACTICE: INTERIM ANALYSIS OF THE ITALIAN Master-Entas COHORT STUDY OF PATIENTS WITH CHRONIC HEPATITIS BAlfieri, A. / Fasano, M. / Brancaccio, G. / Santantonio, T. / Malfatti, F. / Marzano, A. / Bronte, F. / Caccamo, G. / Fagiuoli, S. / Morisco, F. et al. | 2013
- S311
-
765 TWELVE-MONTHS ENTECAVIR LONGITUDINAL CHANGES IN LIVER FIBROSIS, ACTIVITY AS PER FibroTest-FibroMax AND LIVER STIFFNESS MEASUREMENTS IN CHRONIC HEPATITIS B. STEATOSIS IMPACT ON FIBROSIS REGRESSIONZoulim, F. / Causse, X. / Leroy, V. / Ouzan, D. / Ganne, N. / Bourcier, V. / de Ledinghen, V. / Mathurin, P. / Moussalli, J. / Rudler, M. et al. | 2013
- S313
-
770 STOPPING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY BEFORE HBsAg LOSS IN HBeAg NEGATIVE CHB PATIENTS: FOLLOW-UP OF LONG TERM RESPONDERSPetersen, J. / Buggisch, P. / Hinrichsen, H. / Berg, T. / Wedemeyer, H. / Cornberg, M. / Stoehr, A. et al. | 2013
- S316
-
777 INCIDENCE AND CLINICAL CONSEQUENCES OF REDUCED TUBULAR PHOSPHATE RE-ABSORPTION (TmPO4/GFR) IN NAIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH TENOFOVIR: A TWO-YEAR FIELD STUDYVigano, M. / Lampertico, P. / Mangia, G. / Soffredini, R. / Facchetti, F. / Invernizzi, F. / Colombo, M. et al. | 2013
- S317
-
780 A CLINICAL STUDY ON ANTI-HBV-DC-MTL COMBINED WITH TELBIVUDINE IN THE HBeAg POSITIVE CHRONIC HEPATITIS B VIRUS INFECTIONWu, B. F. / Yang, J. Y. / Liu, Y. / Wang, X. Q. / Huang, X. H. / Xiao, Z. S. / Li, X. S. / Yang, M. / Zhou, Y. / Yang, J. et al. | 2013
- S318
-
782 THE aa15-17 AMINO ACID SEQUENCE IN THE TERMINAL PROTEIN DOMAIN OF HBV POLYMERASE AS A VIRAL FACTOR AFFECTING IN VIVO REPLICATION ACTIVITY OF THE VIRUSYoshino, K. / Sugawara, K. / Uchida, Y. / Kouyama, J. / Naiki, K. / Nakayama, N. / Mochida, S. et al. | 2013
- S319
-
785 CONTINUED LOW UPTAKE OF TREATMENT FOR HCV IN A LARGE COMMUNITY-BASED COHORT OF INNER CITY RESIDENTSAlavi, M. / Raffa, J. D. / Deans, G. D. / Lai, C. / Krajden, M. / Dore, G. J. / Tyndall, M. W. / Grebely, J. et al. | 2013
- S320
-
787 PREVALENCE OF PERSONALITY DISORDER IN SPANISH PENITENTIARY POPULATION. SUBANALYSIS OF PERSEO STUDYMarco Mourino, A. / Anton Basanta, J. J. / Sainz de la Hoya, P. / de Juan Ramirez, J. / Faraco, I. et al. | 2013
- S322
-
791 VIROLOGIC RESPONSE RATES ARE SIMILAR IN PREVIOUSLY UNTREATED AND PREVIOUSLY TREATED AND RELAPSED PATIENTS RECEIVING BOCEPREVIR TRIPLE THERAPY: A RETROSPECTIVE ANALYSISBacon, B. R. / Poordad, F. / Bronowicki, J. P. / Esteban, R. / Thompson, S. / Helmond, F. et al. | 2013
- S324
-
795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOTBichoupan, K. / Martel-Laferriere, V. / Ng, M. / Schonfeld, E. A. / Pappas, A. / Crismale, J. / Stivala, A. / Khaitova, V. / Gardenier, D. / Perumalswami, P. et al. | 2013
- S326
-
799 EFFICACY AND SAFETY OF TRIPLE-THERAPY WITH PEGINTERFERON-RIBAVIRIN, AND BOCEPREVIR AS COMPASSIONATE-USE IN SPANISH PATIENTS WITH HEPATITIS C GENOTYPE 1 WITH SEVERE FIBROSIS: INTERIM-ANALYSIS AT 12 WEEKSCalleja, J. L. / Pascasio, J. M. / Ruiz-Antoran, B. / Larrubia, J. R. / Gea, F. / de la Revilla, J. / Forns, X. / Barcena, R. / Romero-Gomez, M. / Crespo, J. et al. | 2013
- S327
-
801 LONG-TERM EVOLUTION OF LIVER FIBROSIS IN MILD-MODERATE CHRONIC HEPATITIS C: STUDY WITH PAIRED BIOPSIESCanete, N. / Garcia, M. / Ojanguren, I. / Cirera, I. / Garcia- Retortillo, M. / Carrion, J. A. / Puigvehi, M. / Gimenez, M. D. / Marquez, C. / Coll, S. et al. | 2013
- S328
-
804 EXPOSURE-RESPONSE ANALYSES OF ASUNAPREVIR IN COMBINATION WITH DACLATASVIR PEGINTERFERON/ RIBAVIRIN AMONG PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION: DOSE SELECTION FOR PHASE 3 CLINICAL TRIALSChan, P. / Tafoya, E. / Eley, T. / He, B. / Mendez, P. / Gardiner, D. / Hughes, E. / Schnittman, S. / Bertz, R. J. et al. | 2013
- S329
-
806 MANAGEMENT AND OUTCOMES OF ANEMIA IN THE INTERNATIONAL TELAPREVIR EARLY ACCESS PROGRAM, FOR PATIENTS WITH HEPATITIS C GENOTYPE 1 INFECTIONColombo, M. / Fernandez, I. / Abdurakhmanov, D. / Ferreira, P. A. / Strasser, S. / Urbanek, P. / Moreno, C. / Streinu-Cercel, A. / Beeldens, F. / Iraqi, W. et al. | 2013
- S330
-
808 MODELING HCV KINETICS DURING INTRAVENOUS SILIBININ MONOTHERAPY IN THE PERI-TRANSPLANT PERIODDebRoy, S. / Marino, Z. / Crespo, G. / Navasa, M. / DAmato, M. / Cotler, S. J. / Forns, X. / Dahari, H. et al. | 2013
- S333
-
814 TUMOR NECROSIS FACTOR G-308A PROMOTER POLYMORPHISM: ASSOCIATED WITH THE TYPE OF RESPONSE TO ANTIVIRAL THERAPY IN CHRONIC HEPATITIS C?Ferreira, J. / Baldaia, C. / Campelo, D. / Bicho, M. / Velosa, J. / Serejo, F. et al. | 2013
- S334
-
816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSISJanczewska, E. / Flisiak, R. / Berak, H. / Zarebska-Michaluk, D. / Dobracka, B. / Pisula, A. / Horban, A. / Kryczka, W. / Dobracki, W. / Librant-Suska, M. et al. | 2013
- S336
-
821 INTERFERON (IFN)-FREE ALISPORIVIR (ALV) HAS A BETTER OVERALL SAFETY PROFILE COMPARED TO IFN-CONTAINING TREATMENT: A POOLED ANALYSIS OF THE ALV DEVELOPMENT PROGRAMGriffel, L. / Bao, W. / Orsenigo, R. / Guo, V. / Wu, M. / Loeffler, J. / Brass, C. / Avila, C. / Naoumov, N. V. et al. | 2013
- S338
-
826 SAFETY AND EFFICACY OF TWICE DAILY VERSUS EVERY 8 HOUR TELAPREVIR WITH PEGINTERFERON/RIBAVIRIN (PR) IN PATIENTS WITH CIRRHOSISHorsmans, Y. / Brown, R. S. / Buti, M. / Agarwal, K. / Sievert, W. / Janczewska, E. / Zeuzem, S. / Nyberg, L. / Hezode, C. / Rizzetto, M. et al. | 2013
- S339
-
829 IFN-BASED HCV-TREATMENT SEEMS TO REDUCE MUSCLE MASSHuth, K. / Leweling, H. / Ebert, M. / Antoni, C. et al. | 2013
- S340
-
831 DELAYED DECLINE OF ON-TREATMENT HEMOGLOBIN WAS ASSOCIATED WITH BETTER SUSTAINED VIROLOGICAL RESPONSES IN GENOTYPE-2 CHRONIC HEPATITIS C PATIENTS RECEIVING PEG-IFN/RBV TREATMENTJeng, W. J. / Lin, C. Y. / Huang, C. W. / Huang, C. H. / Chen, W. T. / Chang, T. C. / Sheen, I. S. et al. | 2013
- S342
-
835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIAKarino, Y. / Ozeki, I. / Hige, S. / Miyakawa, M. / Kimura, M. / Arakawa, T. / Nakajima, T. / Kuwata, Y. / Sato, T. / Ohmura, T. et al. | 2013
- S343
-
838 INITIATION AND DISCONTINUATION OF INTERFERONCONTAINING THERAPY AMONG HIV/HCV CO-INFECTED PATIENTS IN A US COMMERCIALLY-INSURED POPULATIONKirbach, S. / Wong, B. J. / Kruse, G. B. / Gooch, K. L. et al. | 2013
- S344
-
840 EFFECT OF THERAPEUTIC DOSES OF ALISPORIVIR (ALV) ON METHADONE PHARMACOKINETICS IN HEALTHY SUBJECTS AND PATIENTS ON STABLE METHADONE MAINTENANCE THERAPY (MMT)Kovacs, S. J. / Ke, J. / Barve, A. / Cheng, Y. / Zhang, J. / Maietta, R. / Sunkara, G. / Stein, D. S. et al. | 2013
- S345
-
843 DEVELOPMENT OF TUBERCULOSIS IN PATIENTS ON INTERFERON TREATMENT FOR HCV RELATED CLDKumar, N. / Shah, V. / Kumar, R. / Sarin, S. K. et al. | 2013
- S348
-
850 EARLY VIROLOGIC RESPONSE (EVR) IN TREATMENT-NAIVE MONO-INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH CEPEGINTERFERON-alfa-2b (cePEG-IFNa-2b) PLUS RIBAVIRINZnoyko, O. / Maevskaya, M. / Klimova, E. / Kizhlo, S. / Petrochenkova, N. / Maximov, S. / Nagimova, F. / Ivanov, R. / Linkova, Y. / Chernovskaya, T. et al. | 2013
- S349
-
853 ANEMIA IN A COHORT OF PATIENTS WITH CHRONIC HEPATITIS C ON TRIPLE THERAPYLlop, E. / Cabezas, J. / Selmo, J. / de la Revilla, J. / Martinez, J. L. / Menendez, S. / Pons, F. / Torres, K. / Trapero, M. / Crespo, J. et al. | 2013
- S350
-
855 A CLINICAL TRIAL EVALUATING LOW HCVRNA VIREMIA IN PATIENTS TREATED WITH TRIPLE THERAPY REGIMENS: IMPLICATIONS FOR PATIENT MANAGEMENT USING DIFFERENT ASSAYS IN CLINICAL PRACTICEMaasoumy, B. / Cobb, B. / Halfon, P. / Aslam, S. / Bremer, B. / Manns, M. P. / Cornberg, M. / Wedemeyer, H. et al. | 2013
- S351
-
858 COULD PEG-INTERFERON AND RIBAVIRIN BE EFFECTIVE AND SAFE IN THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C?Madonia, S. / Barone, R. / Restivo Pantalone, G. / Sinagra, E. / Perricone, G. / Renda, M. C. / Piazza, A. / Maggio, A. / Cottone, M. et al. | 2013
- S352
-
860 REVISTING PREDICTORS OF VIROLOGIC RESPONSE TO PEGIFN+RBV THERAPY IN HIV/HCV COINFECTED PATIENTS: THE ROLE OF METABOLIC FACTORS AND ELEVATED GGT LEVELSMandorfer, M. / Reiberger, T. / Payer, B. A. / Breitenecker, F. / Aichelburg, M. C. / Obermayer-Pietsch, B. / Rieger, A. / Puoti, M. / Zangerle, R. / Trauner, M. et al. | 2013
- S353
-
862 THE IMPACT OF IL28B rs12979860 SNP ON THE ASSOCIATION BETWEEN TREATMENT DURATION AND SUSTAINED VIROLOGIC RESPONSE IN HIV/HCV COINFECTED PATIENTSMandorfer, M. / Reiberger, T. / Payer, B. A. / Neukam, K. / Rivero, A. / Puoti, M. / Ernst, D. / Boesecke, C. / Baumgarten, A. / Jaroszewicz, J. et al. | 2013
- S354
-
864 ITPA ACTIVITY PREDICTS Hb DECLINE AFTER FOUR WEEKS OF PI TRIPLE THERAPY, REGARDLESS OF PREVIOUS TREATMENT OR NAIVE STATUS AND FIBROSIS: A MULTICENTER REAL-LIFE EXPERIENCEMangia, A. / Clark, P. J. / Piazzolla, V. / Santoro, R. / Holmes, J. A. / Mottola, L. / Ripoli, M. / Iser, D. / Nguyen, T. / Bell, S. J. et al. | 2013
- S356
-
868 TREATMENT WITH TELAPREVIR-BASED THERAPY AFTER EXPOSURE TO PEG-IFN/RBV IN THE REALIZE STUDY: RESULTS FROM THE PHASE IIIB C219 ROLLOVER STUDYMathurin, P. / Sarrazin, C. / Reesink, H. W. / Weiland, O. / Diago, M. / Dusheiko, G. / Ascione, A. / Ben-Ari, Z. / Lyra, L. G. / Sievert, W. et al. | 2013
- S357
-
871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDYMauss, S. / Boeker, K. H. / Eisenbach, C. / Moeller, B. / Moog, G. / Lutz, T. / Naumann, U. / Christensen, S. / Jung, M. C. / Teuber, G. et al. | 2013
- S358
-
873 A SCORING MODEL FOR PREDICTION OF RELAPSE AMONG CHRONIC HCV GENOTYPE 4 PATIENTS TREATED WITH PEG INTERFERON AND RIBAVIRINShahin, Y. / Metwally, M. A. / Shaheen, W. / El Fiky, H. / Moawad, S. et al. | 2013